Cluster composition

Functions

Category	Name	IntersectionWithQuery	PValue	GenesInTerm	GenesInQuery	GenesInTermInQuery	ID
GeneOntologyMolecularFunction	protein serine kinase activity	CDK9 CDK16 CDK18 TSSK2 CDKL4 SRPK1 CDK14 SGK2 SBK1 MYO3A CSNK1A1L CSNK1A1 MYO3B PAK3 PRKG1 PRKG2 TSSK3 DYRK2	3.11e-10	363	151	18	GO:0106310
GeneOntologyMolecularFunction	protein serine/threonine kinase activity	CDK9 CDK16 CDK18 TSSK2 CDKL4 SRPK1 CDK14 SGK2 SBK1 MYO3A CSNK1A1L EGFR CSNK1A1 MYO3B PAK3 PRKG1 PRKG2 TSSK3 DYRK2	1.23e-09	446	151	19	GO:0004674
GeneOntologyMolecularFunction	deaminase binding	HNRNPCL1 HNRNPC HNRNPCL3 HNRNPCL2	3.14e-09	4	151	4	GO:1990827
GeneOntologyMolecularFunction	protein kinase activity	CDK9 CDK16 CDK18 TSSK2 CDKL4 SRPK1 CDK14 SGK2 SBK1 MYO3A CSNK1A1L EGFR CSNK1A1 BTK MYO3B PAK3 PRKG1 PRKG2 TSSK3 DYRK2	2.81e-08	600	151	20	GO:0004672
GeneOntologyMolecularFunction	kinase activity	CDK9 CDK16 CDK18 TSSK2 CDKL4 SRPK1 CDK14 AK7 SGK2 SBK1 MYO3A CSNK1A1L EGFR CSNK1A1 BTK MYO3B PAK3 ETNK1 PRKG1 PRKG2 TSSK3 DYRK2	7.18e-08	764	151	22	GO:0016301
GeneOntologyMolecularFunction	phosphotransferase activity, alcohol group as acceptor	CDK9 CDK16 CDK18 TSSK2 CDKL4 SRPK1 CDK14 SGK2 SBK1 MYO3A CSNK1A1L EGFR CSNK1A1 BTK MYO3B PAK3 ETNK1 PRKG1 PRKG2 TSSK3 DYRK2	9.16e-08	709	151	21	GO:0016773
GeneOntologyMolecularFunction	transferase activity, transferring phosphorus-containing groups	CDK9 CDK16 CDK18 TSSK2 CDKL4 SRPK1 CDK14 AK7 SGK2 SBK1 MYO3A CSNK1A1L EGFR CSNK1A1 BTK MYO3B PAK3 ETNK1 PRKG1 PRKG2 TSSK3 DYRK2	2.29e-06	938	151	22	GO:0016772
GeneOntologyMolecularFunction	cyclin-dependent protein serine/threonine kinase activity	CDK9 CDK16 CDK18 CDKL4 CDK14	2.83e-06	30	151	5	GO:0004693
GeneOntologyMolecularFunction	cyclin-dependent protein kinase activity	CDK9 CDK16 CDK18 CDKL4 CDK14	2.83e-06	30	151	5	GO:0097472
GeneOntologyMolecularFunction	N6-methyladenosine-containing RNA reader activity	HNRNPCL1 HNRNPC HNRNPCL3 HNRNPCL2	4.02e-06	15	151	4	GO:1990247
GeneOntologyMolecularFunction	poly(U) RNA binding	HNRNPCL1 RPS7 HNRNPC HNRNPCL3 HNRNPCL2	5.39e-06	34	151	5	GO:0008266
GeneOntologyMolecularFunction	poly-pyrimidine tract binding	HNRNPCL1 RPS7 HNRNPC HNRNPCL3 HNRNPCL2	1.08e-05	39	151	5	GO:0008187
GeneOntologyMolecularFunction	magnesium ion binding	TSSK2 SRPK1 IDH3B ADCY2 PGM3 CSNK1A1L CSNK1A1 TSSK3 TOP2A DYRK2	1.91e-05	247	151	10	GO:0000287
GeneOntologyMolecularFunction	protein-RNA adaptor activity	HNRNPCL1 HNRNPC HNRNPCL3 HNRNPCL2	2.97e-05	24	151	4	GO:0140517
GeneOntologyMolecularFunction	telomerase RNA binding	HNRNPCL1 HNRNPC HNRNPCL3 HNRNPCL2	3.51e-05	25	151	4	GO:0070034
GeneOntologyMolecularFunction	cGMP-dependent protein kinase activity	PRKG1 PRKG2	5.68e-05	2	151	2	GO:0004692
GeneOntologyMolecularFunction	Rab GDP-dissociation inhibitor activity	GDI1 GDI2	5.68e-05	2	151	2	GO:0005093
GeneOntologyMolecularFunction	glycine:sodium symporter activity	SLC6A9 SLC6A5	1.70e-04	3	151	2	GO:0015375
GeneOntologyMolecularFunction	procollagen-proline 3-dioxygenase activity	P3H2 P3H1	1.70e-04	3	151	2	GO:0019797
GeneOntologyMolecularFunction	peptidyl-proline 3-dioxygenase activity	P3H2 P3H1	3.37e-04	4	151	2	GO:0031544
GeneOntologyMolecularFunction	DNA topoisomerase type II (double strand cut, ATP-hydrolyzing) activity	TOP2A TOP2B	3.37e-04	4	151	2	GO:0003918
GeneOntologyMolecularFunction	enzyme inhibitor activity	HNRNPCL1 KDM5A RPS7 NAIP WFDC6 BIRC6 HNRNPC HNRNPCL3 SMCR8 HNRNPCL2 SORL1	4.84e-04	435	151	11	GO:0004857
GeneOntologyMolecularFunction	amino acid:sodium symporter activity	SLC6A9 SLC6A5 SLC6A14	6.72e-04	23	151	3	GO:0005283
GeneOntologyMolecularFunction	ribonucleoprotein complex binding	HNRNPCL1 HNRNPC EIF3CL HNRNPCL3 EIF3C TOP2B HNRNPCL2	9.90e-04	206	151	7	GO:0043021
GeneOntologyMolecularFunction	amino acid:monoatomic cation symporter activity	SLC6A9 SLC6A5 SLC6A14	1.34e-03	29	151	3	GO:0005416
GeneOntologyMolecularFunction	procollagen-proline dioxygenase activity	P3H2 P3H1	1.54e-03	8	151	2	GO:0019798
GeneOntologyMolecularFunction	neutral L-amino acid:sodium symporter activity	SLC6A9 SLC6A5	1.54e-03	8	151	2	GO:0005295
GeneOntologyMolecularFunction	DNA topoisomerase activity	TOP2A TOP2B	1.54e-03	8	151	2	GO:0003916
GeneOntologyMolecularFunction	single-stranded RNA binding	HNRNPCL1 RPS7 HNRNPC HNRNPCL3 HNRNPCL2	1.56e-03	111	151	5	GO:0003727
GeneOntologyMolecularFunction	molecular function inhibitor activity	HNRNPCL1 KDM5A RPS7 NAIP WFDC6 BIRC6 HNRNPC HNRNPCL3 MICU1 SMCR8 HNRNPCL2 SORL1	1.94e-03	596	151	12	GO:0140678
GeneOntologyMolecularFunction	cyclic nucleotide-dependent protein kinase activity	PRKG1 PRKG2	1.98e-03	9	151	2	GO:0004690
GeneOntologyMolecularFunction	organic acid:sodium symporter activity	SLC6A9 SLC6A5 SLC6A14	2.32e-03	35	151	3	GO:0005343
GeneOntologyMolecularFunction	enzyme regulator activity	HNRNPCL1 KDM5A RPS7 NAIP ASAP3 PSD3 WFDC6 WDR81 GDI1 BIRC6 GDI2 HNRNPC HNRNPCL3 GTF2F1 EGFR BTK ALDH1A1 DMWD SMCR8 HNRNPCL2 SORL1	2.33e-03	1418	151	21	GO:0030234
GeneOntologyMolecularFunction	glycine transmembrane transporter activity	SLC6A9 SLC6A5	2.46e-03	10	151	2	GO:0015187
GeneOntologyBiologicalProcess	negative regulation of mRNA modification	HNRNPCL1 HNRNPC HNRNPCL3 HNRNPCL2	3.88e-08	6	149	4	GO:0090367
GeneOntologyBiologicalProcess	regulation of mRNA modification	HNRNPCL1 HNRNPC HNRNPCL3 HNRNPCL2	9.00e-08	7	149	4	GO:0090365
GeneOntologyBiologicalProcess	negative regulation of telomere maintenance via telomerase	HNRNPCL1 HNRNPC HNRNPCL3 HNRNPCL2	2.94e-05	25	149	4	GO:0032211
GeneOntologyBiologicalProcess	mRNA modification	HNRNPCL1 HNRNPC HNRNPCL3 HNRNPCL2	3.45e-05	26	149	4	GO:0016556
GeneOntologyBiologicalProcess	positive regulation of single stranded viral RNA replication via double stranded DNA intermediate	TOP2A TOP2B	5.18e-05	2	149	2	GO:0045870
GeneOntologyBiologicalProcess	3'-UTR-mediated mRNA stabilization	HNRNPCL1 HNRNPC HNRNPCL3 HNRNPCL2	7.07e-05	31	149	4	GO:0070935
GeneOntologyBiologicalProcess	peptidyl-serine phosphorylation	TSSK2 SRPK1 SGK2 MYO3A CSNK1A1L NRXN1 EGFR CSNK1A1 MYO3B DYRK2	8.14e-05	307	149	10	GO:0018105
GeneOntologyBiologicalProcess	negative regulation of telomere maintenance via telomere lengthening	HNRNPCL1 HNRNPC HNRNPCL3 HNRNPCL2	9.09e-05	33	149	4	GO:1904357
GeneOntologyBiologicalProcess	peptidyl-serine modification	TSSK2 SRPK1 SGK2 MYO3A CSNK1A1L NRXN1 EGFR CSNK1A1 MYO3B DYRK2	1.12e-04	319	149	10	GO:0018209
GeneOntologyCellularComponent	nucleoplasmic periphery of the nuclear pore complex	HNRNPCL1 HNRNPC HNRNPCL3 HNRNPCL2	3.58e-08	6	148	4	GO:1990826
GeneOntologyCellularComponent	telomerase holoenzyme complex	HNRNPCL1 HNRNPC HNRNPCL3 HNRNPCL2	2.72e-05	25	148	4	GO:0005697
GeneOntologyCellularComponent	pronucleus	HNRNPCL1 HNRNPC HNRNPCL3 HNRNPCL2	4.33e-05	28	148	4	GO:0045120
GeneOntologyCellularComponent	basement membrane	COL5A1 COL6A1 FRAS1 TNC P3H2 P3H1	2.34e-04	122	148	6	GO:0005604
GeneOntologyCellularComponent	lamellar body membrane	ABCA3 ABCA12	2.96e-04	4	148	2	GO:0097232
GeneOntologyCellularComponent	sarcoplasmic reticulum	COL6A1 CACNA2D1 MTMR12 SGCD P3H2	4.06e-04	88	148	5	GO:0016529
Domain	Kinase-like_dom	CDK9 CDK16 CDK18 TSSK2 WDR81 CDKL4 SRPK1 CDK14 SGK2 SBK1 MYO3A CSNK1A1L EGFR CSNK1A1 BTK MYO3B PAK3 ETNK1 PRKG1 PRKG2 TSSK3 DYRK2	3.17e-10	542	148	22	IPR011009
Domain	Ser/Thr_kinase_AS	CDK9 CDK16 CDK18 TSSK2 CDKL4 SRPK1 CDK14 SGK2 SBK1 MYO3A CSNK1A1L CSNK1A1 MYO3B PAK3 PRKG1 PRKG2 TSSK3 DYRK2	4.89e-10	357	148	18	IPR008271
Domain	S_TKc	CDK9 CDK16 CDK18 TSSK2 CDKL4 SRPK1 CDK14 SGK2 SBK1 MYO3A CSNK1A1L CSNK1A1 MYO3B PAK3 PRKG1 PRKG2 TSSK3 DYRK2	5.35e-10	359	148	18	SM00220
Domain	PROTEIN_KINASE_ST	CDK9 CDK16 CDK18 TSSK2 CDKL4 SRPK1 CDK14 SGK2 SBK1 MYO3A CSNK1A1L CSNK1A1 MYO3B PAK3 PRKG1 PRKG2 TSSK3 DYRK2	6.11e-10	362	148	18	PS00108
Domain	PROTEIN_KINASE_ATP	CDK9 CDK16 CDK18 TSSK2 CDKL4 SRPK1 CDK14 SGK2 SBK1 MYO3A CSNK1A1L EGFR CSNK1A1 BTK MYO3B PAK3 PRKG1 PRKG2 TSSK3 DYRK2	6.43e-10	459	148	20	PS00107
Domain	Protein_kinase_ATP_BS	CDK9 CDK16 CDK18 TSSK2 SRPK1 CDK14 SGK2 MYO3A CSNK1A1L EGFR CSNK1A1 BTK MYO3B PAK3 PRKG1 PRKG2 TSSK3 DYRK2	1.27e-09	379	148	18	IPR017441
Domain	Pkinase	CDK9 CDK16 CDK18 TSSK2 CDKL4 SRPK1 CDK14 SGK2 SBK1 MYO3A CSNK1A1L CSNK1A1 MYO3B PAK3 PRKG1 PRKG2 TSSK3 DYRK2	1.38e-09	381	148	18	PF00069
Domain	Prot_kinase_dom	CDK9 CDK16 CDK18 TSSK2 CDKL4 SRPK1 CDK14 SGK2 SBK1 MYO3A CSNK1A1L EGFR CSNK1A1 BTK MYO3B PAK3 PRKG1 PRKG2 TSSK3 DYRK2	1.92e-09	489	148	20	IPR000719
Domain	PROTEIN_KINASE_DOM	CDK9 CDK16 CDK18 TSSK2 CDKL4 SRPK1 CDK14 SGK2 SBK1 MYO3A CSNK1A1L EGFR CSNK1A1 BTK MYO3B PAK3 PRKG1 PRKG2 TSSK3 DYRK2	2.20e-09	493	148	20	PS50011
Domain	hnRNP_C	HNRNPCL1 HNRNPC HNRNPCL4 HNRNPCL2	5.61e-08	6	148	4	IPR017347
Domain	RRM	HNRNPCL1 PPIL4 RBM42 ABT1 NCL HNRNPC SAFB SAFB2 HNRNPCL4 HNRNPCL2	1.53e-05	230	148	10	PS50102
Domain	-	HNRNPCL1 PPIL4 RBM42 ABT1 NCL HNRNPC SAFB SAFB2 HNRNPCL4 HNRNPCL2	2.54e-05	244	148	10	3.30.70.330
Domain	Nucleotide-bd_a/b_plait	HNRNPCL1 PPIL4 RBM42 ABT1 NCL HNRNPC SAFB SAFB2 HNRNPCL4 HNRNPCL2	4.08e-05	258	148	10	IPR012677
Domain	RRM_1	HNRNPCL1 PPIL4 RBM42 NCL HNRNPC SAFB SAFB2 HNRNPCL4 HNRNPCL2	4.27e-05	208	148	9	PF00076
Domain	RRM	HNRNPCL1 PPIL4 RBM42 NCL HNRNPC SAFB SAFB2 HNRNPCL4 HNRNPCL2	5.93e-05	217	148	9	SM00360
Domain	-	TOP2A TOP2B	6.24e-05	2	148	2	3.40.50.670
Domain	DTHCT	TOP2A TOP2B	6.24e-05	2	148	2	IPR012542
Domain	DNA_gyraseB	TOP2A TOP2B	6.24e-05	2	148	2	PF00204
Domain	RabGDI	GDI1 GDI2	6.24e-05	2	148	2	IPR000806
Domain	-	TOP2A TOP2B	6.24e-05	2	148	2	3.90.199.10
Domain	TopoIIA_CS	TOP2A TOP2B	6.24e-05	2	148	2	IPR018522
Domain	EIF3C_N_dom	EIF3CL EIF3C	6.24e-05	2	148	2	IPR008905
Domain	cGMP_dep_kinase	PRKG1 PRKG2	6.24e-05	2	148	2	IPR002374
Domain	eIF-3c_N	EIF3CL EIF3C	6.24e-05	2	148	2	PF05470
Domain	Topo_IIA	TOP2A TOP2B	6.24e-05	2	148	2	IPR001241
Domain	DNA_topoisoIV	TOP2A TOP2B	6.24e-05	2	148	2	PF00521
Domain	Topo_IIA_A/C_ab	TOP2A TOP2B	6.24e-05	2	148	2	IPR013758
Domain	Topo_IIA_A_a	TOP2A TOP2B	6.24e-05	2	148	2	IPR013757
Domain	Topo_IIA_cen_dom	TOP2A TOP2B	6.24e-05	2	148	2	IPR013759
Domain	TOP4c	TOP2A TOP2B	6.24e-05	2	148	2	SM00434
Domain	TOP2c	TOP2A TOP2B	6.24e-05	2	148	2	SM00433
Domain	Topo_IIA-like_dom	TOP2A TOP2B	6.24e-05	2	148	2	IPR013760
Domain	Topo_IIA_bsu_dom2	TOP2A TOP2B	6.24e-05	2	148	2	IPR013506
Domain	DTHCT	TOP2A TOP2B	6.24e-05	2	148	2	PF08070
Domain	-	TOP2A TOP2B	6.24e-05	2	148	2	1.10.268.10
Domain	TOPRIM_C	TOP2A TOP2B	6.24e-05	2	148	2	IPR031660
Domain	TOPRIM_C	TOP2A TOP2B	6.24e-05	2	148	2	PF16898
Domain	EIF3C	EIF3CL EIF3C	6.24e-05	2	148	2	IPR027516
Domain	Topo_IIA_A/C	TOP2A TOP2B	6.24e-05	2	148	2	IPR002205
Domain	TOPOISOMERASE_II	TOP2A TOP2B	6.24e-05	2	148	2	PS00177
Domain	-	CFAP251 COPB2 WDR81 BIRC6 SORT1 WDR3 TECPR2 TLE3 IFT122 LRBA DMWD	7.15e-05	333	148	11	2.130.10.10
Domain	WD40/YVTN_repeat-like_dom	CFAP251 COPB2 WDR81 BIRC6 SORT1 WDR3 TECPR2 TLE3 IFT122 LRBA DMWD	7.54e-05	335	148	11	IPR015943
Domain	RRM_dom	HNRNPCL1 PPIL4 RBM42 NCL HNRNPC SAFB SAFB2 HNRNPCL4 HNRNPCL2	8.39e-05	227	148	9	IPR000504
Domain	-	COL5A1 FAT4 SVEP1 ADGRG6 NRXN1 LRBA	1.09e-04	95	148	6	2.60.120.200
Domain	Arg_repress_C-like	TOP2A TOP2B	1.86e-04	3	148	2	IPR024946
Domain	-	TOP2A TOP2B	1.86e-04	3	148	2	3.30.1360.40
Domain	WD40	CFAP251 COPB2 WDR81 WDR3 TECPR2 TLE3 IFT122 LRBA DMWD	2.91e-04	268	148	9	SM00320
Domain	WD40_repeat	CFAP251 COPB2 WDR81 WDR3 TECPR2 TLE3 IFT122 LRBA DMWD	3.25e-04	272	148	9	IPR001680
Domain	NA_NEUROTRAN_SYMP_2	SLC6A9 SLC6A5 SLC6A14	3.65e-04	18	148	3	PS00754
Domain	HATPase_c	MORC1 TOP2A TOP2B	3.65e-04	18	148	3	SM00387
Domain	VDCC_a2/dsu	CACNA2D1 CACNA2D3	3.70e-04	4	148	2	IPR013680
Domain	Toprim	TOP2A TOP2B	3.70e-04	4	148	2	PF01751
Domain	VGCC_alpha2	CACNA2D1 CACNA2D3	3.70e-04	4	148	2	PF08473
Domain	GDI	GDI1 GDI2	3.70e-04	4	148	2	PF00996
Domain	Toprim_domain	TOP2A TOP2B	3.70e-04	4	148	2	IPR006171
Domain	GDP_dissociation_inhibitor	GDI1 GDI2	3.70e-04	4	148	2	IPR018203
Domain	TOPRIM	TOP2A TOP2B	3.70e-04	4	148	2	PS50880
Domain	WD_REPEATS_1	CFAP251 COPB2 WDR81 WDR3 TECPR2 TLE3 IFT122 LRBA DMWD	3.81e-04	278	148	9	PS00678
Domain	WD_REPEATS_2	CFAP251 COPB2 WDR81 WDR3 TECPR2 TLE3 IFT122 LRBA DMWD	3.91e-04	279	148	9	PS50082
Domain	WD_REPEATS_REGION	CFAP251 COPB2 WDR81 WDR3 TECPR2 TLE3 IFT122 LRBA DMWD	3.91e-04	279	148	9	PS50294
Domain	SNF	SLC6A9 SLC6A5 SLC6A14	4.30e-04	19	148	3	PF00209
Domain	Na/ntran_symport	SLC6A9 SLC6A5 SLC6A14	4.30e-04	19	148	3	IPR000175
Domain	HATPase_c	MORC1 TOP2A TOP2B	4.30e-04	19	148	3	PF02518
Domain	NA_NEUROTRAN_SYMP_1	SLC6A9 SLC6A5 SLC6A14	4.30e-04	19	148	3	PS00610
Domain	NA_NEUROTRAN_SYMP_3	SLC6A9 SLC6A5 SLC6A14	4.30e-04	19	148	3	PS50267
Domain	-	MORC1 TOP2A TOP2B	5.03e-04	20	148	3	3.30.565.10
Domain	HATPase_C	MORC1 TOP2A TOP2B	5.84e-04	21	148	3	IPR003594
Domain	WD40_repeat_dom	CFAP251 COPB2 WDR81 WDR3 TECPR2 TLE3 IFT122 LRBA DMWD	6.14e-04	297	148	9	IPR017986
Domain	VWA_N	CACNA2D1 CACNA2D3	6.14e-04	5	148	2	IPR013608
Domain	VWA_N	CACNA2D1 CACNA2D3	6.14e-04	5	148	2	PF08399
Domain	Sortilin_C	SORT1 SORL1	6.14e-04	5	148	2	PF15901
Domain	Sortilin-Vps10	SORT1 SORL1	6.14e-04	5	148	2	PF15902
Domain	VPS10	SORT1 SORL1	6.14e-04	5	148	2	IPR006581
Domain	Sortilin_N	SORT1 SORL1	6.14e-04	5	148	2	IPR031778
Domain	Sortilin_C	SORT1 SORL1	6.14e-04	5	148	2	IPR031777
Domain	VPS10	SORT1 SORL1	6.14e-04	5	148	2	SM00602
Domain	VWA	COL6A1 CACNA2D1 SVEP1 CACNA2D3	1.01e-03	56	148	4	PF00092
Domain	WD40	CFAP251 COPB2 WDR81 WDR3 TLE3 IFT122 LRBA DMWD	1.09e-03	259	148	8	PF00400
Domain	BIR	NAIP BIRC6	1.69e-03	8	148	2	PF00653
Domain	BIR_REPEAT_2	NAIP BIRC6	1.69e-03	8	148	2	PS50143
Domain	BIR	NAIP BIRC6	1.69e-03	8	148	2	SM00238
Domain	-	NAIP BIRC6	1.69e-03	8	148	2	1.10.1170.10
Domain	BIR_rpt	NAIP BIRC6	1.69e-03	8	148	2	IPR001370
Domain	BIR_REPEAT_1	NAIP BIRC6	1.69e-03	8	148	2	PS01282
Domain	ConA-like_dom	COL5A1 FAT4 SVEP1 ADGRG6 FSD1L NRXN1 LRBA	1.83e-03	219	148	7	IPR013320
Domain	fn3	FNDC3B MYOM1 TNC FNDC3A FSD1L SORL1	1.86e-03	162	148	6	PF00041
Domain	CNMP_BINDING_1	PRKG1 PRKG2 PNPLA7	2.04e-03	32	148	3	PS00888
Domain	CNMP_BINDING_2	PRKG1 PRKG2 PNPLA7	2.04e-03	32	148	3	PS00889
Domain	BEACH	WDR81 LRBA	2.16e-03	9	148	2	PS50197
Domain	Beach	WDR81 LRBA	2.16e-03	9	148	2	PF02138
Domain	-	WDR81 LRBA	2.16e-03	9	148	2	1.10.1540.10
Domain	Beach	WDR81 LRBA	2.16e-03	9	148	2	SM01026
Domain	BEACH_dom	WDR81 LRBA	2.16e-03	9	148	2	IPR000409
Domain	cNMP	PRKG1 PRKG2 PNPLA7	2.44e-03	34	148	3	SM00100
Domain	cNMP_binding	PRKG1 PRKG2 PNPLA7	2.44e-03	34	148	3	PF00027
Domain	cNMP-bd_dom	PRKG1 PRKG2 PNPLA7	2.65e-03	35	148	3	IPR000595
Domain	CNMP_BINDING_3	PRKG1 PRKG2 PNPLA7	2.65e-03	35	148	3	PS50042
Domain	PTX	SVEP1 ADGRG6	2.69e-03	10	148	2	SM00159
Domain	-	COL6A1 CACNA2D1 SVEP1 CACNA2D3	2.83e-03	74	148	4	3.40.50.410
Domain	Pentaxin-related	SVEP1 ADGRG6	3.27e-03	11	148	2	IPR001759
Pathway	WP_MRNA_PROCESSING	CDK9 HNRNPCL1 RPS7 PPIL4 RBM42 SRPK1 NCL HNRNPC HNRNPCL3 SAFB2 TMED10 MRPL11 HNRNPCL2 ILKAP	2.18e-05	451	117	14	MM15946
Pathway	REACTOME_RHOBTB2_GTPASE_CYCLE	HNRNPCL1 HNRNPC HNRNPCL3 HNRNPCL2	4.98e-05	25	117	4	MM15606
Pathway	REACTOME_RHOBTB1_GTPASE_CYCLE	HNRNPCL1 HNRNPC HNRNPCL3 HNRNPCL2	4.98e-05	25	117	4	MM15608
Pubmed	Protein kinase CK1alpha regulates mRNA binding by heterogeneous nuclear ribonucleoprotein C in response to physiologic levels of hydrogen peroxide.	HNRNPCL1 HNRNPC HNRNPCL3 CSNK1A1L CSNK1A1 HNRNPCL2	6.06e-15	6	151	6	15687492
Pubmed	KCTD13-mediated ubiquitination and degradation of GluN1 regulates excitatory synaptic transmission and seizure susceptibility.	GPM6A ATXN2L CACNA2D1 HNRNPCL1 TNC SPTB RPS7 COPB2 PSD3 NCL CHD3 PRDX2 IDH3B MDH1 GDI1 GDI2 HNRNPC EIF3CL HNRNPCL3 TGM1 SAFB CSNK1A1L TTC7B CSNK1A1 SEC16A EIF3C HNRNPCL2 PRRC2B CACNA2D3	3.86e-12	1431	151	29	37142655
Pubmed	Anticancer sulfonamides target splicing by inducing RBM39 degradation via recruitment to DCAF15.	ATXN2L RPS7 COPB2 PPIL4 SRPK1 NCL CHD3 PRDX2 MDH1 GDI1 GDI2 HNRNPC SVEP1 HNRNPCL3 SAFB SAFB2 EIF3C MRPL11 TOP2A TOP2B	4.62e-11	714	151	20	28302793
Pubmed	The splicing factor hnRNP C regulates expression of co-stimulatory molecules CD80 and CD40 in dendritic cells.	HNRNPCL1 HNRNPC HNRNPCL3 HNRNPCL2	3.41e-10	4	151	4	23831410
Pubmed	hnRNPC induces isoform shifts in miR-21-5p leading to cancer development.	HNRNPCL1 HNRNPC HNRNPCL3 HNRNPCL2	3.41e-10	4	151	4	35729324
Pubmed	N6-methylation of RNA-bound adenosine regulator HNRNPC promotes vascular endothelial dysfunction in type 2 diabetes mellitus by activating the PSEN1-mediated Notch pathway.	HNRNPCL1 HNRNPC HNRNPCL3 HNRNPCL2	3.41e-10	4	151	4	36681355
Pubmed	hnRNP C is required for postimplantation mouse development but Is dispensable for cell viability.	HNRNPCL1 HNRNPC HNRNPCL3 HNRNPCL2	3.41e-10	4	151	4	10805751
Pubmed	Heterogeneous nuclear ribonucleoprotein C1 may control miR-30d levels in endometrial exosomes affecting early embryo implantation.	HNRNPCL1 HNRNPC HNRNPCL3 HNRNPCL2	1.70e-09	5	151	4	29846695
Pubmed	Characterization of two nuclear proteins that interact with cytochrome P-450 1A2 mRNA. Regulation of RNA binding and possible role in the expression of the Cyp1a2 gene.	HNRNPCL1 HNRNPC HNRNPCL3 HNRNPCL2	1.70e-09	5	151	4	9128719
Pubmed	Evaluating the role of hnRNP-C and FMRP in the cAMP-induced APP metabolism.	HNRNPCL1 HNRNPC HNRNPCL3 HNRNPCL2	1.70e-09	5	151	4	25809670
Pubmed	Opposite Dysregulation of Fragile-X Mental Retardation Protein and Heteronuclear Ribonucleoprotein C Protein Associates with Enhanced APP Translation in Alzheimer Disease.	HNRNPCL1 HNRNPC HNRNPCL3 HNRNPCL2	5.09e-09	6	151	4	26048669
Pubmed	Selective disruption of genes expressed in totipotent embryonal stem cells.	HNRNPCL1 HNRNPC HNRNPCL3 HNRNPCL2	5.09e-09	6	151	4	1317320
Pubmed	Concomitant transitory up-regulation of X-linked inhibitor of apoptosis protein (XIAP) and the heterogeneous nuclear ribonucleoprotein C1-C2 in surviving cells during neuronal apoptosis.	HNRNPCL1 HNRNPC HNRNPCL3 HNRNPCL2	5.09e-09	6	151	4	18363099
Pubmed	TBK1 phosphorylation activates LIR-dependent degradation of the inflammation repressor TNIP1.	ATXN2L HNRNPCL1 RPS7 COPB2 ABT1 NCL PRDX2 HNRNPC EIF3CL HNRNPCL3 WDR3 TGM1 SAFB CSNK1A1 SAFB2 HNRNPCL4 TUBA4B EIF3C TOP2A HNRNPCL2	6.20e-09	949	151	20	36574265
Pubmed	Large-scale characterization of HeLa cell nuclear phosphoproteins.	ATXN2L KDM5A NCL CHD3 HNRNPC BAP1 EIF3CL MYO3A SAFB EGFR USP42 TLE3 SEC16A SAFB2 EIF3C DMWD TOP2A TOP2B	8.44e-09	774	151	18	15302935
Pubmed	Quantitative analysis of HSP90-client interactions reveals principles of substrate recognition.	CDK9 CDK18 TSSK2 SRPK1 CDK14 SGK2 EGFR CSNK1A1 BTK MYO3B PRKG2 TSSK3 DYRK2	1.03e-08	372	151	13	22939624
Pubmed	MECP2 directly interacts with RNA polymerase II to modulate transcription in human neurons.	CDK9 NRDE2 HNRNPCL1 KDM5A RPS7 COPB2 PPIL4 RBM42 NCL PRDX2 HNRNPC VANGL2 SAFB NRXN1 USP42 DHRS7 PGRMC2 SAFB2 EIF3C MTCH1 TOP2B	1.05e-08	1082	151	21	38697112
Pubmed	Age-related expression analysis of mouse liver nuclear protein binding to 3'-untranslated region of Period2 gene.	HNRNPCL1 HNRNPC HNRNPCL3 HNRNPCL2	1.18e-08	7	151	4	25846207
Pubmed	Identifications of novel host cell factors that interact with the receptor-binding domain of the SARS-CoV-2 spike protein.	FNDC3B NRDE2 FRAS1 MTMR12 HNRNPCL1 SRPK1 NCL CHD3 ZZEF1 NPLOC4 HNRNPCL3 GTF2F1 HNRNPCL4 IFT122 PRRC2B SORL1	2.75e-08	650	151	16	38777146
Pubmed	Small subfamily of olfactory receptor genes: structural features, expression pattern and genomic organization.	HNRNPCL1 HNRNPC HNRNPCL3 HNRNPCL2	4.23e-08	9	151	4	10452948
Pubmed	In-Depth In Vivo Crosslinking in Minutes by a Compact, Membrane-Permeable, and Alkynyl-Enrichable Crosslinker.	HNRNPCL1 KDM5A RPS7 RBM42 NCL CHD3 HNRNPC HNRNPCL3 SAFB NRXN1 SAFB2 IFT122 ALDH1A1 ABCC2 DMWD DTHD1 MRPL11 TOP2A TOP2B HNRNPCL2 SLC4A11 SLC6A14 PRRC2B	7.22e-08	1442	151	23	35575683
Pubmed	The enzymatic activity of SR protein kinases 1 and 1a is negatively affected by interaction with scaffold attachment factors B1 and 2.	SRPK1 SAFB SAFB2	8.02e-08	3	151	3	19674106
Pubmed	Matrix-screening reveals a vast potential for direct protein-protein interactions among RNA binding proteins.	FNDC3B HNRNPCL1 RPS7 PPIL4 RBM42 ABT1 NCL HNRNPC EIF3CL HNRNPCL3 WDR3 GTF2F1 USP42 EIF3C HNRNPCL2 PRRC2B	1.17e-07	723	151	16	34133714
Pubmed	Interaction between nucleosome assembly protein 1-like family members.	HNRNPCL1 HNRNPC HNRNPCL3 HNRNPCL2	1.64e-07	12	151	4	21333655
Pubmed	The biogenesis of the coiled body during early mouse development.	HNRNPCL1 HNRNPC HNRNPCL3 HNRNPCL2	1.64e-07	12	151	4	7768196
Pubmed	Cyclin Y, a novel membrane-associated cyclin, interacts with PFTK1.	CDK16 RB1 CDK14	3.20e-07	4	151	3	19524571
Pubmed	SAFB1 interacts with and suppresses the transcriptional activity of p53.	SRPK1 SAFB SAFB2	3.20e-07	4	151	3	21130767
Pubmed	LCP1 preferentially binds clasped αMβ2 integrin and attenuates leukocyte adhesion under flow.	ATXN2L HNRNPCL1 NCL GDI1 BIRC6 HNRNPC EIF3CL HNRNPCL3 BTK EIF3C HNRNPCL2	3.54e-07	344	151	11	30333137
Pubmed	The protein interaction landscape of the human CMGC kinase group.	CDK9 CDK16 CDK18 HNRNPCL1 RB1 WDR81 SRPK1 NCL CDK14 HNRNPC TLE3 FIBP PRKG2 SORL1 DYRK2	4.09e-07	695	151	15	23602568
Pubmed	Synthetic Lethal and Resistance Interactions with BET Bromodomain Inhibitors in Triple-Negative Breast Cancer.	CDK9 RB1 COPB2 PPIL4 ABT1 NCL CHD3 MDH1 GDI2 NPLOC4 WDR3 GTF2F1 SAFB CSNK1A1 SAFB2 TOP2A TOP2B ILKAP	4.73e-07	1014	151	18	32416067
Pubmed	The mRNA-bound proteome and its global occupancy profile on protein-coding transcripts.	ATXN2L HNRNPCL1 RPS7 PPIL4 SRPK1 ABT1 NCL GDI2 HNRNPC GTF2F1 SAFB SAFB2 EIF3C MRPL11 TOP2A PRRC2B	5.09e-07	807	151	16	22681889
Pubmed	Genome-wide CRISPR screen identifies HNRNPL as a prostate cancer dependency regulating RNA splicing.	COL5A1 SPTB NAIP CHD3 CDK14 HNRNPC NPLOC4 ADGRG6 SGK2 ZNF331 MICU1 SBK1 EGFR TECPR2 CSNK1A1 TLE3 PAK3 RASEF IFT122 PNPLA7 LRBA FRMD3	5.24e-07	1489	151	22	28611215
Pubmed	Targeted and Interactome Proteomics Revealed the Role of PHD2 in Regulating BRD4 Proline Hydroxylation.	CDK9 ATXN2L RPS7 PPIL4 NCL HNRNPC PGM3 GTF2F1 SAFB SAFB2 EIF3C TOP2A	5.70e-07	441	151	12	31239290
Pubmed	Targeting USP10 induces degradation of oncogenic ANLN in esophageal squamous cell carcinoma.	CDK9 ATXN2L RPS7 PPIL4 SRPK1 ABT1 NCL PRDX2 GDI1 SQOR HNRNPC EIF3CL MICU1 WDR3 SAFB EGFR CSNK1A1 SAFB2 MRPL11 TOP2A	5.82e-07	1257	151	20	36526897
Pubmed	Rho-associated protein kinase-dependent moesin phosphorylation is required for PD-L1 stabilization in breast cancer.	PRDX2 IDH3B MDH1 GDI2 WDR3 TGM1 SEC16A LRBA TMED10	6.49e-07	224	151	9	32941674
Pubmed	Proteomic and yeast 2-hybrid screens to identify PTEN binding partners.	HNRNPCL1 PRDX2 SQOR GDI2 HNRNPC HNRNPCL3 P3H1 ALDH1A1 HNRNPCL2	6.99e-07	226	151	9	37839992
Pubmed	N-Terminal Acetyltransferase Naa40p Whereabouts Put into N-Terminal Proteoform Perspective.	ATXN2L NEBL NCL CHD3 PRDX2 NPLOC4 SAFB PGRMC2 SEC16A SAFB2 EIF3C LRBA SMCR8 TOP2A TOP2B PRRC2B ILKAP	7.16e-07	934	151	17	33916271
Pubmed	A method to identify cDNAs based on localization of green fluorescent protein fusion products.	HNRNPCL1 HNRNPC HNRNPCL3 HNRNPCL2	7.78e-07	17	151	4	10716735
Pubmed	Presynaptic α2δ-2 Calcium Channel Subunits Regulate Postsynaptic GABAA Receptor Abundance and Axonal Wiring.	CACNA2D1 NRXN1 CACNA2D3	1.59e-06	6	151	3	30683685
Pubmed	A High-Density Human Mitochondrial Proximity Interaction Network.	FNDC3A NCL IDH3B ZZEF1 BIRC6 GDI2 HNRNPC ELOVL2 MICU1 VANGL2 WDR3 BNIP3L DHRS7 PGRMC2 SEC16A TMED10 SMCR8 MRPL11 MTCH1 TOP2A PRRC2B	2.19e-06	1496	151	21	32877691
Pubmed	Misregulation of Alternative Splicing in a Mouse Model of Rett Syndrome.	HNRNPCL1 HNRNPC HNRNPCL3 SAFB2 HNRNPCL2	2.36e-06	49	151	5	27352031
Pubmed	Multiplexed kinase interactome profiling quantifies cellular network activity and plasticity.	CDK9 NRDE2 SRPK1 IDH3B CDK14 EIF3CL CSNK1A1L EGFR CSNK1A1 BTK PGRMC2 FIBP PAK3 EIF3C PRKG1 DYRK2	2.42e-06	910	151	16	36736316
Pubmed	Identification of toposome, a novel multisubunit complex containing topoisomerase IIalpha.	SRPK1 HNRNPC TOP2A	2.77e-06	7	151	3	15034300
Pubmed	The synovial sarcoma SYT-SSX2 oncogene remodels the cytoskeleton through activation of the ephrin pathway.	CSNK1A1L EGFR CSNK1A1	2.77e-06	7	151	3	17686994
Pubmed	The HIV-1 Tat protein recruits a ubiquitin ligase to reorganize the 7SK snRNP for transcriptional activation.	CDK9 CDK16 ATXN2L CDK18 HNRNPCL1 KDM5A RPS7 COPB2 SRPK1 NCL CHD3 PRDX2 CDK14 HNRNPC AK7 TUBA4B EIF3C MRPL11	2.91e-06	1153	151	18	29845934
Pubmed	Control of a neuronal morphology program by an RNA-binding zinc finger protein, Unkempt.	COPB2 NCL GDI1 BIRC6 GDI2 SAFB TOP2A TOP2B PRRC2B	3.12e-06	271	151	9	25737280
Pubmed	Phenotypic and Interaction Profiling of the Human Phosphatases Identifies Diverse Mitotic Regulators.	MTMR12 RPS7 COPB2 PSD3 BIRC6 SORT1 GTF2F1 TTC7B EGFR P3H1 TLE3 PGRMC2 SEC16A EIF3C DMWD PRRC2B ILKAP	3.42e-06	1049	151	17	27880917
Pubmed	Characterizing ZC3H18, a Multi-domain Protein at the Interface of RNA Production and Destruction Decisions.	RPS7 RBM42 SRPK1 ABT1 NCL PRDX2 HNRNPC WDR3 SAFB CSNK1A1 SAFB2 EIF3C MRPL11 TOP2A	4.05e-06	731	151	14	29298432
Pubmed	The Nse5/6-like SIMC1-SLF2 complex localizes SMC5/6 to viral replication centers.	ATXN2L HNRNPCL1 RPS7 PPIL4 NCL CHD3 HNRNPC HNRNPCL3 WDR3 SAFB SEC16A SAFB2 TOP2A TOP2B HNRNPCL2 ILKAP	4.40e-06	954	151	16	36373674
Pubmed	Quantitative Proteomics Reveals Dynamic Interactions of the Minichromosome Maintenance Complex (MCM) in the Cellular Response to Etoposide Induced DNA Damage.	HNRNPCL1 RPS7 NCL CHD3 PRDX2 GDI2 HNRNPC NPLOC4 EIF3CL TGM1 MYO3A SEC16A TUBA4B EIF3C TOP2A	4.46e-06	844	151	15	25963833
Pubmed	Combinatorial targeting of a chromatin complex comprising Dot1L, menin and the tyrosine kinase BAZ1B reveals a new therapeutic vulnerability of endocrine therapy-resistant breast cancer.	CDK9 ATXN2L COL5A1 RPS7 SRPK1 ABT1 NCL CHD3 HNRNPC WDR3 SAFB SAFB2 EIF3C TOP2A TOP2B	4.66e-06	847	151	15	35850772
Pubmed	Stage-specific changes in gene expression in acutely isolated mouse CNS progenitor cells.	HNRNPCL1 HNRNPC HNRNPCL3 HNRNPCL2	4.74e-06	26	151	4	15890332
Pubmed	Spatiotemporal profile of postsynaptic interactomes integrates components of complex brain disorders.	GPM6A CACNA2D1 KDM5A WDR81 NCL PRDX2 GDI1 GDI2 CSNK1A1L NRXN1 CSNK1A1 SEC16A SAFB2 PAK3 TMED10 PRRC2B	4.95e-06	963	151	16	28671696
Pubmed	Regulation of alternative splicing by SRrp86 and its interacting proteins.	HNRNPCL1 SRPK1 NCL HNRNPC SAFB	5.04e-06	57	151	5	14559993
Pubmed	Systematic mapping of genetic interactions for de novo fatty acid synthesis identifies C12orf49 as a regulator of lipid metabolism.	CDK9 ATXN2L KDM5A CYP3A5 MECOM CDK14 GDI1 BIRC6 KHDC4 PGM3 BAP1 MICU1 SLC6A9 SAFB PGRMC2 SEC16A FIBP RASEF TMED10	5.27e-06	1327	151	19	32694731
Pubmed	∆F508 CFTR interactome remodelling promotes rescue of cystic fibrosis.	COPB2 PRDX2 IDH3B GDI1 GDI2 HNRNPC EGFR PGRMC2 SEC16A RASEF LRBA MRPL11 TOP2A	5.44e-06	647	151	13	26618866
Pubmed	Identification by proximity labeling of novel lipidic and proteinaceous potential partners of the dopamine transporter.	GPM6A SLC6A9 PGRMC2 SLC6A5	5.54e-06	27	151	4	34709416
Pubmed	A Human Tyrosine Phosphatase Interactome Mapped by Proteomic Profiling.	MTMR12 COPB2 PPIL4 SRPK1 NCL NPLOC4 PGM3 VANGL2 CSNK1A1L CSNK1A1 SEC16A UMPS EIF3C TMED10 PRRC2B SORL1	5.71e-06	974	151	16	28675297
Pubmed	Cell cycle-dependent phosphorylation regulates RECQL4 pathway choice and ubiquitination in DNA double-strand break repair.	CDK9 ATXN2L RPS7 COPB2 PPIL4 SRPK1 NCL CHD3 PRDX2 GDI1 GDI2 HNRNPC NPLOC4 HNRNPCL3 CSNK1A1L SEC16A EIF3C TMED10 MRPL11	5.74e-06	1335	151	19	29229926
Pubmed	New roles for the de-ubiquitylating enzyme OTUD4 in an RNA-protein network and RNA granules.	ATXN2L HNRNPCL1 NCL SQOR HNRNPC HNRNPCL3 EGFR FIBP HNRNPCL2 PRRC2B DYRK2	6.12e-06	462	151	11	31138677
Pubmed	ZZW-115-dependent inhibition of NUPR1 nuclear translocation sensitizes cancer cells to genotoxic agents.	CDK9 ATXN2L SRPK1 HNRNPC WDR3 SAFB EGFR CSNK1A1 P3H1 SAFB2 EIF3C TOP2A TOP2B	6.74e-06	660	151	13	32780723
Pubmed	MYC multimers shield stalled replication forks from RNA polymerase.	CDK9 SGCD RPS7 PPIL4 ABT1 NCL PRDX2 IDH3B HNRNPC WDR3 SAFB USP42 SAFB2 EIF3C TOP2A TOP2B	6.91e-06	989	151	16	36424410
Pubmed	Systematic bromodomain protein screens identify homologous recombination and R-loop suppression pathways involved in genome integrity.	CDK9 INO80C RB1 KDM5A ABCA12 MECOM CHD3 IDH3B ZZEF1 SQOR VANGL2 SEC16A FIBP TOP2A SLC4A11 PRRC2B SORL1	7.72e-06	1116	151	17	31753913
Pubmed	Hdac4 Interactions in Huntington's Disease Viewed Through the Prism of Multiomics.	ATXN2L CACNA2D1 PSD3 MDH1 GDI2 SAFB CSNK1A1L TTC7B CSNK1A1 TOP2B PRRC2B	7.94e-06	475	151	11	31040226
Pubmed	Genomic analysis of mouse retinal development.	CFAP251 COPB2 PSD3 PRDX2 SLC6A9 BNIP3L CSNK1A1L TTC7B CSNK1A1 PGRMC2 PAK3 ETNK1 PNPLA7 PRRC2B DYRK2 ILKAP	8.54e-06	1006	151	16	15226823
Pubmed	The extracellular matrix gene Frem1 is essential for the normal adhesion of the embryonic epidermis.	COL5A1 COL6A1 FRAS1	9.41e-06	10	151	3	15345741
Pubmed	AMPK, a Regulator of Metabolism and Autophagy, Is Activated by Lysosomal Damage via a Novel Galectin-Directed Ubiquitin Signal Transduction System.	RPS7 SRPK1 NCL PRDX2 IDH3B GDI2 PGRMC2 EIF3C TMED10 TOP2A TOP2B	9.46e-06	484	151	11	31995728
Pubmed	Identification and functional characterization of transcriptional activators in human cells.	CDK9 CDK16 COL6A1 RB1 MECOM WDR3 TLE3 SEC16A IFT122 SMCR8	1.03e-05	398	151	10	35016035
Pubmed	The ubiquitin-dependent ATPase p97 removes cytotoxic trapped PARP1 from chromatin.	RB1 MECOM NCL GDI2 PGM3 WDR3 CSNK1A1 EIF3C TOP2A TOP2B	1.08e-05	400	151	10	35013556
Pubmed	Interactome analyses revealed that the U1 snRNP machinery overlaps extensively with the RNAP II machinery and contains multiple ALS/SMA-causative proteins.	CDK9 HNRNPCL1 COPB2 PRDX2 HNRNPC TGM1 SAFB SAFB2	1.23e-05	244	151	8	29884807
Pubmed	Loss of ER retention motif of AGR2 can impact mTORC signaling and promote cancer metastasis.	RPS7 COPB2 WDR81 NCL PRDX2 MDH1 ZZEF1 GDI2 HNRNPC FSD1L SAFB CSNK1A1 ALDH1A1 LRBA	1.24e-05	807	151	14	30575818
Pubmed	The level of the transcription factor Pax6 is essential for controlling the balance between neural stem cell self-renewal and neurogenesis.	SRPK1 EIF3CL WDR3 BNIP3L PAK3 EIF3C TOP2A TOP2B	1.26e-05	245	151	8	19521500
Pubmed	ATG5 is required for B cell polarization and presentation of particulate antigens.	CDK9 NRDE2 NCL PRDX2 EIF3CL SAFB CSNK1A1L CSNK1A1 SAFB2 EIF3C TOP2A TOP2B PRRC2B	1.28e-05	701	151	13	30196744
Pubmed	Dephosphorylation of the nuclear factor of activated T cells (NFAT) transcription factor is regulated by an RNA-protein scaffold complex.	CSNK1A1L CSNK1A1 DYRK2	1.29e-05	11	151	3	21709260
Pubmed	Assembly of the U5 snRNP component PRPF8 is controlled by the HSP90/R2TP chaperones.	CDK9 RPS7 COPB2 SRPK1 NCL PRDX2 IDH3B MDH1 BIRC6 HNRNPC NPLOC4 GTF2F1 EGFR CSNK1A1 SEC16A EIF3C MRPL11 TOP2A TOP2B	1.30e-05	1415	151	19	28515276
Pubmed	FBW7 suppresses ovarian cancer development by targeting the N6-methyladenosine binding protein YTHDF2.	RPS7 PPIL4 MECOM SRPK1 NCL IDH3B SQOR HNRNPC SEC16A MRPL11 TOP2A TOP2B	1.35e-05	601	151	12	33658012
Pubmed	Joint influence of small-effect genetic variants on human longevity.	COL5A1 NRDE2 SVEP1 NRXN1	1.43e-05	34	151	4	20834067
Pubmed	Proximity-dependent biotin identification (BioID) reveals a dynamic LSD1-CoREST interactome during embryonic stem cell differentiation.	COL6A1 KDM5A MECOM CHD3 MDH1 BIRC6 BAP1 TLE3 SEC16A LRBA	1.57e-05	418	151	10	34709266
Pubmed	Nucleolar proteome dynamics.	CDK9 SRPK1 ABT1 CHD3 HNRNPC WDR3 GTF2F1 CSNK1A1 TOP2A TOP2B	1.60e-05	419	151	10	15635413
Pubmed	WWP2 ubiquitylates RNA polymerase II for DNA-PK-dependent transcription arrest and repair at DNA breaks.	CDK9 ATXN2L RPS7 SRPK1 NCL HNRNPC SAFB P3H1 EIF3C TOP2A TOP2B PRRC2B	1.69e-05	615	151	12	31048545
Pubmed	Cyclin-dependent kinases: a family portrait.	CDK16 CDK18 CDK14	1.72e-05	12	151	3	19884882
Pubmed	BAP1 regulation of the key adaptor protein NCoR1 is critical for γ-globin gene repression.	KDM5A RPS7 SRPK1 NCL PRDX2 HNRNPC BAP1 EIF3CL WDR3 SAFB USP42 BTK SEC16A SAFB2 LRBA TMED10 TOP2A TOP2B	1.79e-05	1318	151	18	30463901
Pubmed	Global phosphoproteome analysis on human HepG2 hepatocytes using reversed-phase diagonal LC.	EIF3CL GTF2F1 EGFR EIF3C	1.81e-05	36	151	4	16097034
Pubmed	SND1 binds SARS-CoV-2 negative-sense RNA and promotes viral RNA synthesis through NSP9.	ATXN2L FNDC3B SRPK1 HNRNPC HNRNPCL3 SAFB2 EIF3C PRRC2B	1.83e-05	258	151	8	37794589
Pubmed	Irisin Mediates Effects on Bone and Fat via αV Integrin Receptors.	FNDC3B COL6A1 RPS7 COPB2 PPIL4 NCL ADAMTS5 PRDX2 GCNT2 IDH3B SQOR CSGALNACT2 EGFR P3H1 DHRS7 PGRMC2 SEC16A PNPLA7 TMED10	1.84e-05	1451	151	19	30550785
Pubmed	DNA topoisomerase II is dispensable for oocyte meiotic resumption but is essential for meiotic chromosome condensation and separation in mice.	TOP2A TOP2B	1.87e-05	2	151	2	24048577
Pubmed	Involvement of nuclear protein C23 in activation of EGFR signaling in cervical cancer.	NCL EGFR	1.87e-05	2	151	2	26254615
Pubmed	Increased mitochondrial function downstream from KDM5A histone demethylase rescues differentiation in pRB-deficient cells.	RB1 KDM5A	1.87e-05	2	151	2	26314709
Pubmed	RB loss in resistant EGFR mutant lung adenocarcinomas that transform to small-cell lung cancer.	RB1 EGFR	1.87e-05	2	151	2	25758528
Pubmed	Use of divalent metal ions in the dna cleavage reaction of human type II topoisomerases.	TOP2A TOP2B	1.87e-05	2	151	2	19222228
Pubmed	SubID, a non-median dichotomization tool for heterogeneous populations, reveals the pan-cancer significance of INPP4B and its regulation by EVI1 in AML.	MECOM INPP4B	1.87e-05	2	151	2	29415082
Pubmed	Interaction of cCMP with the cGK, cAK and MAPK Kinases in Murine Tissues.	PRKG1 PRKG2	1.87e-05	2	151	2	25978317
Pubmed	Cloning and expression of a novel cyclic GMP-dependent protein kinase from mouse brain.	PRKG1 PRKG2	1.87e-05	2	151	2	8514791
Pubmed	Evidence for a mutant allele of the gene for DNA topoisomerase II in adriamycin-resistant P388 murine leukemia cells.	TOP2A TOP2B	1.87e-05	2	151	2	2555055
Pubmed	Scaffold attachment factors SAFB1 and SAFB2: Innocent bystanders or critical players in breast tumorigenesis?	SAFB SAFB2	1.87e-05	2	151	2	14587024
Pubmed	Molecular biology of mammalian amino acid transporters.	SLC6A9 SLC6A5	1.87e-05	2	151	2	8811182
Pubmed	Characterization of cDNA encoding the mouse DNA topoisomerase II that can complement the budding yeast top2 mutation.	TOP2A TOP2B	1.87e-05	2	151	2	1331984
Pubmed	Impaired relaxation of stomach smooth muscle in mice lacking cyclic GMP-dependent protein kinase I.	PRKG1 PRKG2	1.87e-05	2	151	2	10694248
Pubmed	Developmental expression of the glycine transporters GLYT1 and GLYT2 in mouse brain.	SLC6A9 SLC6A5	1.87e-05	2	151	2	8667011
Pubmed	Genome-wide profiling of non-smoking-related lung cancer cells reveals common RB1 rearrangements associated with histopathologic transformation in EGFR-mutant tumors.	RB1 EGFR	1.87e-05	2	151	2	31959344
Interaction	RBM39 interactions	CDK9 ATXN2L RPS7 COPB2 PPIL4 RBM42 MECOM SRPK1 NCL CHD3 PRDX2 MDH1 GDI1 GDI2 KHDC4 HNRNPC SVEP1 BAP1 HNRNPCL3 SAFB EGFR SEC16A SAFB2 EIF3C MRPL11 TOP2A TOP2B	1.09e-08	1042	149	27	int:RBM39
Interaction	EIF3G interactions	RPS7 RBM42 FNDC3A NCL CHD3 BAP1 EIF3CL EGFR EIF3C PRRC2B DYRK2	2.53e-06	249	149	11	int:EIF3G
Interaction	CDK9 interactions	CDK9 ATXN2L RB1 SPTB RPS7 COPB2 PPIL4 NCL PRDX2 IDH3B HNRNPC GTF2F1 SAFB EGFR CSNK1A1 FIBP ALDH1A1 ILKAP	3.23e-06	685	149	18	int:CDK9
Interaction	HNRNPU interactions	CDK9 CACNA2D1 RB1 RPS7 COPB2 RBM42 MECOM SRPK1 FNDC3A NCL CHD3 BIRC6 HNRNPC BAP1 WDR3 GTF2F1 SAFB EGFR EIF3C MTCH1 TOP2A DYRK2	7.63e-06	1035	149	22	int:HNRNPU
Interaction	SRRM1 interactions	RPS7 RBM42 SRPK1 ABT1 NCL CHD3 BAP1 GTF2F1 SAFB EGFR TOP2A TOP2B	1.11e-05	348	149	12	int:SRRM1
Interaction	RPS19 interactions	CDK9 ATXN2L HNRNPCL1 RPS7 PPIL4 RBM42 MECOM ABT1 NCL CHD3 HNRNPC BAP1 HNRNPCL3 GTF2F1 EGFR HNRNPCL2	2.13e-05	639	149	16	int:RPS19
Interaction	CIT interactions	CDK9 ATXN2L SPTB RPS7 COPB2 PPIL4 RBM42 SRPK1 NCL CHD3 ZZEF1 SQOR BIRC6 HNRNPC EIF3CL HNRNPCL3 WDR3 SAFB BNIP3L CSNK1A1L SAFB2 HNRNPCL4 TUBA4B TOP2A TOP2B HNRNPCL2	2.15e-05	1450	149	26	int:CIT
Interaction	HNRNPCL3 interactions	HNRNPCL1 HNRNPC HNRNPCL3 HNRNPCL2	2.28e-05	23	149	4	int:HNRNPCL3
Interaction	RPS11 interactions	CDK9 ATXN2L RPS7 RBM42 ABT1 NCL CHD3 BAP1 EIF3CL EGFR EIF3C TOP2A PRRC2B ILKAP	2.38e-05	505	149	14	int:RPS11
Interaction	LMNA interactions	CDK16 CMTM3 RB1 RPS7 PPIL4 MECOM NCL CHD3 MDH1 GDI2 HNRNPC NPLOC4 FAIM BNIP3L CSGALNACT2 NRXN1 EGFR CSNK1A1 DHRS7 PGRMC2 SEC16A TOP2A TOP2B ILKAP	2.46e-05	1286	149	24	int:LMNA
Interaction	PATE1 interactions	CACNA2D1 ZZEF1 BIRC6 EGFR SORL1	3.03e-05	49	149	5	int:PATE1
Interaction	RB1CC1 interactions	ATXN2L MECOM BAP1 SAFB EGFR CSNK1A1 SEC16A SAFB2 UMPS TMED10 SMCR8 DYRK2	3.17e-05	387	149	12	int:RB1CC1
Interaction	PLXNA4 interactions	GPM6A HNRNPCL1 HNRNPCL3 HNRNPCL2	5.12e-05	28	149	4	int:PLXNA4
Interaction	RPL4 interactions	CDK9 RPS7 RBM42 SRPK1 ABT1 NCL CHD3 PRDX2 BAP1 EIF3CL WDR3 EGFR CSNK1A1 HNRNPCL4 TOP2A DYRK2 ILKAP	5.16e-05	764	149	17	int:RPL4
Interaction	RRS1 interactions	CDK9 RPS7 MECOM SRPK1 ABT1 NCL GDI2 HNRNPC EGFR MRPL11 HNRNPCL2	5.32e-05	345	149	11	int:RRS1
Interaction	TIMP3 interactions	COL6A1 FRAS1 WFDC6 ZZEF1 TMED10 SORL1	5.52e-05	90	149	6	int:TIMP3
Interaction	RFC1 interactions	RB1 RPS7 MECOM NCL CHD3 BAP1 CSNK1A1 TOP2A HNRNPCL2	5.68e-05	231	149	9	int:RFC1
Interaction	FKBP5 interactions	CDK9 CDK18 TSSK2 CDKL4 PRDX2 BAP1 SGK2 EGFR CSNK1A1 TLE3 TOP2A TOP2B	6.07e-05	414	149	12	int:FKBP5
Interaction	ZFP41 interactions	FRAS1 NCL SAFB SAFB2 SORL1	6.35e-05	57	149	5	int:ZFP41
Interaction	FGR interactions	CDK9 CDK18 HNRNPCL1 CDK14 HNRNPC EGFR	6.63e-05	93	149	6	int:FGR
Interaction	HSP90AA5P interactions	CDK9 CDK18 CDKL4 CDK14 SGK2 BTK	6.63e-05	93	149	6	int:HSP90AA5P
Interaction	RACK1 interactions	CDK9 RB1 RPS7 RBM42 SRPK1 FNDC3A NCL CHD3 BIRC6 BAP1 EGFR TLE3 EIF3C TOP2A PRRC2B DYRK2	6.78e-05	704	149	16	int:RACK1
Interaction	TMT1A interactions	COPB2 FNDC3A ELOVL2 NPLOC4 VANGL2 DHRS7 PGRMC2 SEC16A LRBA TMED10 SMCR8	7.59e-05	359	149	11	int:TMT1A
Interaction	SFSWAP interactions	AKNAD1 RBM42 CHD3 EGFR LRBA CACNA2D3	7.92e-05	96	149	6	int:SFSWAP
Interaction	ST7 interactions	FRAS1 FNDC3A SQOR ELOVL2 NPLOC4 VANGL2 TGM1 DHRS7 PGRMC2 SEC16A SMCR8	8.18e-05	362	149	11	int:ST7
Interaction	COPB2 interactions	CDK9 COPB2 PSD3 SRPK1 PRDX2 BIRC6 HNRNPC BAP1 EGFR DHRS7 TMED10	9.92e-05	370	149	11	int:COPB2
Interaction	PSPC1 interactions	CDK9 ATXN2L RPS7 PPIL4 SRPK1 NCL HNRNPC BAP1 WDR3 EGFR EIF3C TOP2B PRRC2B	1.21e-04	515	149	13	int:PSPC1
Interaction	USP39 interactions	RBM42 SRPK1 NCL CHD3 HNRNPC BAP1 SAFB EGFR	1.28e-04	201	149	8	int:USP39
Interaction	FOXA1 interactions	ATXN2L SRPK1 ABT1 CHD3 PRDX2 HNRNPC SAFB EGFR CSNK1A1 TLE3 SEC16A MRPL11 TOP2A	1.46e-04	525	149	13	int:FOXA1
Interaction	EIF3C interactions	RBM42 MECOM NCL CHD3 EIF3CL EGFR EIF3C TMED10 PRRC2B	1.52e-04	263	149	9	int:EIF3C
Interaction	ATG13 interactions	RPS7 HNRNPC EIF3CL SAFB SAFB2 EIF3C SMCR8 TOP2A	1.62e-04	208	149	8	int:ATG13
Interaction	LRRC59 interactions	CDK9 ATXN2L CMTM3 RPS7 FNDC3A CHD3 ELOVL2 BAP1 VANGL2 GTF2F1 NRXN1 P3H1 DHRS7 PGRMC2 EIF3C TMED10 SMCR8	1.74e-04	845	149	17	int:LRRC59
Interaction	RAB11B interactions	RBM42 GDI1 GDI2 BAP1 PRKG2 ABCC2 TMED10	1.76e-04	158	149	7	int:RAB11B
Interaction	CHMP4C interactions	HNRNPCL1 SPTB COPB2 NCL PRDX2 GDI2 HNRNPC WDR3 SAFB CSNK1A1L SEC16A SAFB2 TUBA4B TOP2A TOP2B	1.79e-04	687	149	15	int:CHMP4C
Interaction	MECP2 interactions	CDK9 ATXN2L NRDE2 HNRNPCL1 KDM5A RPS7 COPB2 PPIL4 RBM42 NCL PRDX2 HNRNPC VANGL2 SAFB NRXN1 USP42 DHRS7 PGRMC2 SAFB2 EIF3C MTCH1 TOP2B	1.98e-04	1287	149	22	int:MECP2
Interaction	TOP1 interactions	CDK9 ATXN2L PPIL4 SRPK1 NCL CHD3 CDK14 HNRNPC BAP1 GTF2F1 SAFB EGFR SAFB2 TOP2A TOP2B	2.06e-04	696	149	15	int:TOP1
Interaction	LARP7 interactions	CDK9 CDK16 ATXN2L CDK18 HNRNPCL1 KDM5A RPS7 COPB2 RBM42 SRPK1 ABT1 NCL PRDX2 CDK14 HNRNPC AK7 TUBA4B EIF3C MRPL11 DYRK2	2.08e-04	1113	149	20	int:LARP7
Interaction	KLHL20 interactions	ATXN2L HNRNPC SVEP1 WDR3 SAFB SAFB2 TOP2A TOP2B	2.09e-04	216	149	8	int:KLHL20
Interaction	KIF23 interactions	CDK9 ATXN2L COL5A1 RPS7 SRPK1 NCL CHD3 BIRC6 HNRNPC WDR3 SAFB BNIP3L CSNK1A1L EGFR CSNK1A1 SAFB2 TOP2A TOP2B HNRNPCL2	2.20e-04	1031	149	19	int:KIF23
Interaction	TAF15 interactions	CDK9 HNRNPCL1 SRPK1 CHD3 PRDX2 HNRNPC TGM1 SAFB TLE3 SAFB2 TOP2B	2.32e-04	408	149	11	int:TAF15
Interaction	SMC3 interactions	CDK9 COPB2 PSD3 MECOM FNDC3A NCL CHD3 BAP1 EGFR CSNK1A1 TOP2B	2.32e-04	408	149	11	int:SMC3
Interaction	RAB5A interactions	HNRNPCL1 FNDC3A NCL GDI1 GDI2 HNRNPC EIF3CL VANGL2 EGFR TECPR2 PGRMC2 SEC16A EIF3C LRBA SMCR8	2.40e-04	706	149	15	int:RAB5A
Interaction	DDX23 interactions	RPS7 PPIL4 RBM42 SRPK1 NCL CHD3 GTF2F1 SAFB EGFR SAFB2 TOP2A TOP2B	2.42e-04	480	149	12	int:DDX23
Interaction	RBM14 interactions	CDK9 RPS7 MECOM CHD3 CDK14 HNRNPC BAP1 SAFB TLE3 SEC16A SAFB2 TOP2B DYRK2	2.42e-04	553	149	13	int:RBM14
Interaction	EIF4E interactions	CDK9 ATXN2L RBM42 NCL BAP1 WDR3 EGFR EIF3C	2.44e-04	221	149	8	int:EIF4E
Interaction	TRIT1 interactions	FNDC3A EGFR HNRNPCL2	2.50e-04	17	149	3	int:TRIT1
Interaction	SORCS2 interactions	FNDC3A SORT1 SORL1	2.50e-04	17	149	3	int:SORCS2
Interaction	BGLAP interactions	RB1 KDM5A P3H2	2.50e-04	17	149	3	int:BGLAP
Interaction	COPA interactions	COPB2 PSD3 MECOM HNRNPC BAP1 SORT1 EGFR CSNK1A1 DHRS7 EIF3C TMED10	2.53e-04	412	149	11	int:COPA
Interaction	HNRNPC interactions	CDK9 HNRNPCL1 COPB2 SRPK1 CHD3 HNRNPC BAP1 HNRNPCL3 SAFB EGFR CSNK1A1 SAFB2 TOP2A HNRNPCL2	2.64e-04	634	149	14	int:HNRNPC
Interaction	HMGB1 interactions	RB1 NCL PRDX2 HNRNPC BAP1 SAFB EGFR CSNK1A1 SAFB2 TOP2A TOP2B DYRK2	2.71e-04	486	149	12	int:HMGB1
Interaction	CCNT1 interactions	CDK9 ATXN2L RB1 PPIL4 NCL CDK14 GTF2F1 DYRK2	2.75e-04	225	149	8	int:CCNT1
Interaction	FIP1L1 interactions	CDK9 ATXN2L PPIL4 CHD3 BAP1 EGFR SEC16A DYRK2	2.75e-04	225	149	8	int:FIP1L1
Interaction	KIF20A interactions	NEBL SPTB COPB2 NCL CDK14 SQOR HNRNPC HNRNPCL3 WDR3 SAFB CSNK1A1L CSNK1A1 MYO3B SEC16A SAFB2 TOP2A TOP2B HNRNPCL2 PRRC2B	2.84e-04	1052	149	19	int:KIF20A
Interaction	ANXA2 interactions	CDK9 FNDC3B HNRNPCL1 TNC CHD3 PRDX2 HNRNPC BAP1 NRXN1 EGFR HNRNPCL2	2.92e-04	419	149	11	int:ANXA2
Interaction	RPS3 interactions	CDK9 FNDC3B RPS7 RBM42 FNDC3A ABT1 NCL CHD3 BAP1 EIF3CL EGFR USP42 CSNK1A1 BTK TOP2A	3.00e-04	721	149	15	int:RPS3
Interaction	RPS16 interactions	CDK9 RPS7 RBM42 SRPK1 ABT1 NCL CHD3 BAP1 WDR3 EGFR EIF3C TOP2A TOP2B PRRC2B DYRK2	3.14e-04	724	149	15	int:RPS16
Interaction	ISG15 interactions	ATXN2L COPB2 SRPK1 NCL SQOR GDI2 NPLOC4 PGRMC2 SEC16A ALDH1A1 TOP2A TOP2B	3.14e-04	494	149	12	int:ISG15
Interaction	ATP2A1 interactions	FRAS1 MECOM FNDC3A GCNT2 ELOVL2 MICU1 VANGL2 TLE3 DHRS7 PGRMC2 SEC16A	3.16e-04	423	149	11	int:ATP2A1
Interaction	FASN interactions	CDK9 ATXN2L HNRNPCL1 KDM5A MECOM BIRC6 HNRNPC PGM3 BAP1 HNRNPCL3 SLC6A9 SAFB PGRMC2 SEC16A FIBP RASEF TMED10 MTCH1 HNRNPCL2	3.20e-04	1062	149	19	int:FASN
Interaction	HNRNPUL2 interactions	CDK18 HNRNPCL1 RBM42 MECOM CHD3 HNRNPC SEC16A SAFB2 TOP2A	3.23e-04	291	149	9	int:HNRNPUL2
Interaction	NAA40 interactions	ATXN2L NEBL NCL CHD3 PRDX2 NPLOC4 SAFB PGRMC2 SEC16A SAFB2 EIF3C LRBA SMCR8 TOP2A TOP2B HNRNPCL2 PRRC2B ILKAP	3.31e-04	978	149	18	int:NAA40
Interaction	DDX17 interactions	CDK9 ATXN2L MECOM SRPK1 NCL CHD3 HNRNPC BAP1 EGFR P3H1 TLE3	3.36e-04	426	149	11	int:DDX17
Interaction	RAB2B interactions	GDI1 GDI2 BAP1 TMED10 DMWD	3.37e-04	81	149	5	int:RAB2B
Interaction	HSP90AB4P interactions	CDK9 FNDC3B TSSK2 CDKL4 BAP1 SGK2	3.51e-04	126	149	6	int:HSP90AB4P
Interaction	CCL19 interactions	CACNA2D1 FAT4 RB1	3.52e-04	19	149	3	int:CCL19
Interaction	RPS3A interactions	CDK9 FNDC3B RPS7 RBM42 ABT1 NCL CHD3 HNRNPC BAP1 EIF3CL GTF2F1 EGFR EIF3C TOP2A	3.67e-04	655	149	14	int:RPS3A
Interaction	MATR3 interactions	CDK9 HNRNPCL1 COPB2 MECOM SRPK1 CHD3 SQOR HNRNPC BAP1 SAFB EGFR SAFB2 EIF3C ILKAP	3.67e-04	655	149	14	int:MATR3
Interaction	RAB31 interactions	GDI1 GDI2 EGFR ABCC2	3.68e-04	46	149	4	int:RAB31
Interaction	RPS5 interactions	CDK9 RPS7 RBM42 ABT1 NCL CHD3 BAP1 EIF3CL EGFR MRPL11 TOP2A	3.70e-04	431	149	11	int:RPS5
Interaction	RPL27 interactions	RPS7 COPB2 RBM42 ABT1 NCL CHD3 BAP1 EGFR CSNK1A1 TOP2A TOP2B	3.70e-04	431	149	11	int:RPL27
Interaction	HNRNPDL interactions	RB1 RPS7 COPB2 RBM42 SRPK1 CHD3 HNRNPC BAP1 ABCC2 MRPL11	3.87e-04	364	149	10	int:HNRNPDL
Interaction	TTN interactions	FNDC3B MYOM1 MECOM NCL BAP1 EGFR TLE3 TOP2A DYRK2	3.93e-04	299	149	9	int:TTN
Interaction	EIF6 interactions	RBM42 NCL CHD3 BIRC6 BAP1 EGFR FIBP EIF3C TOP2A TOP2B	3.95e-04	365	149	10	int:EIF6
Interaction	PNO1 interactions	RB1 RPS7 NCL CHD3 WDR3 EGFR	3.98e-04	129	149	6	int:PNO1
Interaction	SIRT7 interactions	CDK9 ATXN2L COL5A1 RB1 RPS7 COPB2 SRPK1 NCL GDI1 BIRC6 GDI2 WDR3 SEC16A TOP2A PRRC2B	4.18e-04	744	149	15	int:SIRT7
Interaction	DDX60 interactions	SORT1 WDR3 EGFR EIF3C PRRC2B	4.21e-04	85	149	5	int:DDX60
Interaction	DDA1 interactions	ABCA12 RPS7 COPB2 KHDC4 HNRNPC NPLOC4 BAP1 EGFR SAFB2 DYRK2	4.21e-04	368	149	10	int:DDA1
Interaction	PNN interactions	CDK9 RBM42 MECOM SRPK1 ABT1 NCL BIRC6 HNRNPC VANGL2	4.23e-04	302	149	9	int:PNN
Interaction	CD274 interactions	COPB2 PRDX2 IDH3B MDH1 GDI2 WDR3 TGM1 SEC16A LRBA TMED10	4.30e-04	369	149	10	int:CD274
Interaction	BLNK interactions	CMTM3 WDR81 EGFR BTK	4.34e-04	48	149	4	int:BLNK
Interaction	LGALS9 interactions	RPS7 SRPK1 NCL PRDX2 IDH3B GDI2 PGRMC2 EIF3C ABCC2 TMED10 TOP2A TOP2B SORL1	4.35e-04	588	149	13	int:LGALS9
Interaction	IQCB1 interactions	MDH1 GDI1 SQOR GDI2 BAP1 SORT1 CSGALNACT2 PGRMC2 SEC16A IFT122	4.40e-04	370	149	10	int:IQCB1
Interaction	RPS20 interactions	CDK9 ATXN2L RPS7 RBM42 NCL CHD3 BAP1 EIF3CL EGFR EIF3C TOP2A PRRC2B	4.40e-04	513	149	12	int:RPS20
Interaction	XRCC5 interactions	ASAP3 MECOM FNDC3A NCL CHD3 ZZEF1 HNRNPC BAP1 SAFB EGFR TOP2A TOP2B	4.56e-04	515	149	12	int:XRCC5
Interaction	RAB3A interactions	GPM6A GDI1 GDI2 EGFR TMED10	4.69e-04	87	149	5	int:RAB3A
Interaction	LAIR2 interactions	COL5A1 COL6A1 MECOM EGFR	4.70e-04	49	149	4	int:LAIR2
Interaction	EIF3L interactions	RBM42 MECOM NCL CHD3 BAP1 EIF3CL EIF3C PRRC2B	4.73e-04	244	149	8	int:EIF3L
Interaction	TARDBP interactions	CDK9 GPM6A ATXN2L RB1 RPS7 SRPK1 FNDC3A NCL MDH1 HNRNPC BAP1 EIF3C	4.97e-04	520	149	12	int:TARDBP
Interaction	FUS interactions	CDK9 ATXN2L FNDC3B HNRNPCL1 PPIL4 SRPK1 NCL CHD3 MDH1 HNRNPC NPLOC4 BAP1 SAFB EGFR SAFB2	5.00e-04	757	149	15	int:FUS
Interaction	B3GAT1 interactions	ABCA3 RB1 FNDC3A ELOVL2 VANGL2 DHRS7 PGRMC2 SEC16A LRBA SMCR8	5.09e-04	377	149	10	int:B3GAT1
Interaction	DCAF13 interactions	CDK9 ATXN2L RPS7 PPIL4 WDR81 ABT1 PRDX2 EGFR	5.13e-04	247	149	8	int:DCAF13
Interaction	ACE2 interactions	ATXN2L SPTB RPS7 COPB2 PPIL4 RBM42 SRPK1 NCL CHD3 HNRNPC WDR3 SAFB EGFR SAFB2 EIF3C ALDH1A1 TOP2A TOP2B PRRC2B	5.27e-04	1106	149	19	int:ACE2
Interaction	PRPF19 interactions	RBM42 MECOM NCL CHD3 IDH3B KHDC4 BAP1 EGFR MTCH1 TOP2A SLC4A11	5.31e-04	450	149	11	int:PRPF19
Interaction	RPL31 interactions	CDK9 RPS7 RBM42 SRPK1 ABT1 NCL CHD3 HNRNPC BAP1 WDR3 GTF2F1 EGFR TOP2A TOP2B	5.32e-04	680	149	14	int:RPL31
Interaction	SYT13 interactions	NCL NRXN1	5.35e-04	5	149	2	int:SYT13
Interaction	GOLGA6L1 interactions	MECOM EGFR	5.35e-04	5	149	2	int:GOLGA6L1
Interaction	STPG4 interactions	FNDC3B EGFR	5.35e-04	5	149	2	int:STPG4
Interaction	QKI interactions	HNRNPCL1 RBM42 HNRNPC TGM1 TLE3 HNRNPCL2 PRRC2B	5.39e-04	190	149	7	int:QKI
Interaction	SEC61B interactions	FRAS1 RPS7 FNDC3A NCL ELOVL2 NPLOC4 VANGL2 EGFR P3H1 DHRS7 PGRMC2 SEC16A EIF3C TMED10 SMCR8	5.43e-04	763	149	15	int:SEC61B
Cytoband	7q21.1	CYP3A5 CROT	2.97e-04	8	151	2	7q21.1
Cytoband	7q21-q22	CACNA2D1 CDK14	4.75e-04	10	151	2	7q21-q22
Cytoband	6p24.2	GCNT2 ELOVL2	4.75e-04	10	151	2	6p24.2
Cytoband	3q13	MORC1 UMPS	5.80e-04	11	151	2	3q13
GeneFamily	Cyclin dependent kinases	CDK9 CDK16 CDK18 CDKL4 CDK14	3.25e-07	26	103	5	496
GeneFamily	Myosins, class III\|Deafness associated genes	MYO3A MYO3B	3.21e-05	2	103	2	1099
GeneFamily	WD repeat domain containing	CFAP251 COPB2 WDR81 WDR3 TLE3 IFT122 LRBA DMWD	1.27e-04	262	103	8	362
GeneFamily	RNA binding motif containing	HNRNPCL1 PPIL4 RBM42 NCL HNRNPC SAFB SAFB2	2.17e-04	213	103	7	725
GeneFamily	Fibronectin type III domain containing	FNDC3B MYOM1 TNC FNDC3A FSD1L SORL1	3.08e-04	160	103	6	555
GeneFamily	Topoisomerases	TOP2A TOP2B	4.75e-04	6	103	2	1050
GeneFamily	Ring finger proteins\|Baculoviral IAP repeat containing\|Caspase recruitment domain containing	NAIP BIRC6	8.80e-04	8	103	2	419
GeneFamily	WD repeat domain containing\|BEACH domain containing	WDR81 LRBA	1.13e-03	9	103	2	1230
GeneFamily	ATP binding cassette subfamily A	ABCA3 ABCA12	2.80e-03	14	103	2	805
Coexpression	SCHAEFFER_PROSTATE_DEVELOPMENT_AND_CANCER_BOX4_DN	HNRNPCL1 HNRNPC HNRNPCL3 CSNK1A1L CSNK1A1 HNRNPCL2	6.38e-08	37	150	6	MM570
Coexpression	TABULA_MURIS_SENIS_LUNG_CLASSICAL_MONOCYTE_AGEING	HNRNPCL1 RPS7 NCL PRDX2 MDH1 HNRNPC EIF3CL HNRNPCL3 TMBIM4 EIF3C TMED10 MTCH1 HNRNPCL2	1.65e-06	441	150	13	MM3765
Coexpression	ENK_UV_RESPONSE_KERATINOCYTE_DN	RB1 KDM5A TNC MDH1 CDK14 BNIP3L CSNK1A1 PGRMC2 UMPS TOP2A TOP2B SORL1 DYRK2	4.26e-06	481	150	13	M3898
Coexpression	STEARMAN_LUNG_CANCER_EARLY_VS_LATE_UP	HNRNPCL1 WDR81 HNRNPC HNRNPCL3 ETNK1 MTCH1 HNRNPCL2	1.25e-05	134	150	7	MM748
Coexpression	LAKE_ADULT_KIDNEY_C14_DISTAL_CONVOLUTED_TUBULE	FNDC3B FRAS1 MECOM CDK14 INPP4B LRBA CACNA2D3 FRMD3	2.76e-05	208	150	8	M39233
Coexpression	STARK_PREFRONTAL_CORTEX_22Q11_DELETION_UP	FNDC3A EIF3CL CSNK1A1L TTC7B CSNK1A1 SAFB2 EIF3C PRRC2B	2.76e-05	208	150	8	MM581
Coexpression	TABULA_MURIS_SENIS_SPLEEN_PROERYTHROBLAST_AGEING	CDK9 HNRNPCL1 COPB2 RBM42 NCL PRDX2 IDH3B MDH1 HNRNPC EIF3CL HNRNPCL3 CSNK1A1L CSNK1A1 TMBIM4 EIF3C TMED10 MRPL11 MTCH1 HNRNPCL2	3.05e-05	1144	150	19	MM3843
Coexpression	SUNG_METASTASIS_STROMA_UP	COL5A1 TNC PSD3 SVEP1 BNIP3L PRRC2B	4.17e-05	110	150	6	M9483
Coexpression	GRYDER_PAX3FOXO1_TOP_ENHANCERS	PSD3 CDK14 ZZEF1 GDI2 INPP4B ZNF331 VANGL2 TLE3 TMBIM4 PRKG1 TOP2A	4.95e-05	441	150	11	M172
Coexpression	SMID_BREAST_CANCER_BASAL_DN	ABCA3 NEBL ABCA12 NAIP PSD3 ELOVL2 SVEP1 INPP4B CROT IFT122 ALDH1A1 LRBA CACNA2D3 SORL1	5.15e-05	699	150	14	M4960
Coexpression	LAKE_ADULT_KIDNEY_C15_CONNECTING_TUBULE	FNDC3B FRAS1 NEBL MECOM FNDC3A PRKG1 LRBA	5.98e-05	171	150	7	M39234
Coexpression	GRYDER_PAX3FOXO1_ENHANCERS_IN_TADS	SELENOW PPIL4 PSD3 CDK14 ZZEF1 GDI2 INPP4B ZNF331 VANGL2 TLE3 PGRMC2 TMBIM4 ETNK1 PRKG1 TOP2A PRRC2B DYRK2	6.90e-05	1009	150	17	M157
Coexpression	WAKABAYASHI_ADIPOGENESIS_PPARG_BOUND_8D	RB1 TSSK2 CDK14 ZZEF1 BIRC6 FAIM TLE3 DHRS7 SAFB2 IFT122 ALDH1A1 PNPLA7 TOP2A	9.18e-05	646	150	13	M2419
Coexpression	TABULA_MURIS_SENIS_KIDNEY_KIDNEY_COLLECTING_DUCT_PRINCIPAL_CELL_AGEING	HNRNPCL1 RPS7 CHD3 HNRNPC EIF3CL HNRNPCL3 SORT1 EIF3C TMED10 HNRNPCL2	9.52e-05	394	150	10	MM3724
Coexpression	HADDAD_T_LYMPHOCYTE_AND_NK_PROGENITOR_UP	COL5A1 MECOM INPP4B ADGRG6 ALDH1A1	1.04e-04	81	150	5	M17082
Coexpression	SCHAEFFER_PROSTATE_DEVELOPMENT_6HR_DN	FAT4 FRAS1 HNRNPCL1 CDK14 HNRNPC HNRNPCL3 VANGL2 CSNK1A1L CSNK1A1 ALDH1A1 HNRNPCL2	1.13e-04	484	150	11	MM999
Coexpression	BOQUEST_STEM_CELL_UP	COL5A1 COL6A1 TNC SGCD ELOVL2 SVEP1 EGFR ALDH1A1	1.35e-04	261	150	8	M1834
Coexpression	SILIGAN_TARGETS_OF_EWS_FLI1_FUSION_DN	IDH3B CDK14 LRBA	1.41e-04	18	150	3	M16533
Coexpression	WAKABAYASHI_ADIPOGENESIS_PPARG_BOUND_8D	RB1 TSSK2 CDK14 ZZEF1 BIRC6 FAIM TLE3 DHRS7 SAFB2 IFT122 ALDH1A1 PNPLA7 TOP2A	1.42e-04	675	150	13	MM1073
Coexpression	GSE42088_UNINF_VS_LEISHMANIA_INF_DC_2H_UP	CYP3A5 PSD3 CDK14 GDI1 HNRNPC PGM3 ETNK1	1.59e-04	200	150	7	M9900
Coexpression	GSE7831_UNSTIM_VS_CPG_STIM_PDC_1H_UP	MTMR12 RBM42 CROT CSGALNACT2 TLE3 SEC16A DYRK2	1.59e-04	200	150	7	M6944
Coexpression	LAKE_ADULT_KIDNEY_C16_COLLECTING_SYSTEM_PRINCIPAL_CELLS_CORTEX	FNDC3B FRAS1 MECOM FNDC3A PRKG1 LRBA	1.65e-04	141	150	6	M39235
Coexpression	BONOME_OVARIAN_CANCER_SURVIVAL_SUBOPTIMAL_DEBULKING	CDK16 ATXN2L CDK18 FAT4 RB1 PSD3 FNDC3A CDK14 BNIP3L CSGALNACT2 TLE3	1.67e-04	506	150	11	M253
Coexpression	KRAS.LUNG_UP.V1_DN	MORC1 SGCD SLC6A9 TGM1 ADORA3 SLC6A14	1.72e-04	142	150	6	M2893
CoexpressionAtlas	dev gonad_e13.5_M_InterstitTestis_Sma_top-relative-expression-ranked_500	GPM6A COL6A1 CACNA2D1 TNC SGCD ADAMTS5 SVEP1 EGFR P3H2 PAK3 PRKG1 ALDH1A1	9.56e-06	361	149	12	gudmap_dev gonad_e13.5_M_InterstitTestis_Sma_500
CoexpressionAtlas	FacebaseRNAseq_e10.5_Olfactory Pit_top-relative-expression-ranked_1000	GPM6A COL6A1 CACNA2D1 RB1 TNC PSD3 MECOM CHD3 LY96 GCNT2 ADCY2 ELOVL2 SORT1 SLC6A9 NRXN1 EGFR PAK3 RASEF FRMD3	6.12e-05	984	149	19	Facebase_RNAseq_e10.5_Olfactory Pit_1000
CoexpressionAtlas	FacebaseRNAseq_e10.5_Maxillary Arch_top-relative-expression-ranked_2500_k-means-cluster#1	GPM6A PSD3 WDR81 MECOM CHD3 SORT1 NRXN1 EGFR ETNK1 FRMD3	6.24e-05	306	149	10	Facebase_RNAseq_e10.5_Maxillary Arch_2500_K1
CoexpressionAtlas	dev gonad_e12.5_M_InterstitLeydig_MafB_k-means-cluster#1_top-relative-expression-ranked_1000	COL6A1 CACNA2D1 TNC PSD3 ADAMTS5 ADCY2 SVEP1 EGFR P3H2 TOP2A	6.95e-05	310	149	10	gudmap_dev gonad_e12.5_M_InterstitLeydig_MafB_k1_1000
CoexpressionAtlas	Stromal Cells, St.31-38-44-.SLN, CD45- gp38- CD31- CD44-, Lymph Node, avg-2	FNDC3B COL6A1 CACNA2D1 MYOM1 TNC ADAMTS5 GCNT2 SVEP1 EGFR P3H2 PRKG1 ALDH1A1	8.74e-05	453	149	12	GSM777067_500
CoexpressionAtlas	dev gonad_e12.5_M_InterstitLeydig_MafB_top-relative-expression-ranked_1000	GPM6A COL6A1 CACNA2D1 TNC PSD3 ADAMTS5 ADCY2 SVEP1 PGM3 EGFR P3H2 P3H1 PAK3 ALDH1A1 TOP2A SLC6A14	1.02e-04	768	149	16	gudmap_dev gonad_e12.5_M_InterstitLeydig_MafB_1000
CoexpressionAtlas	dev gonad_e13.5_F_VascAssocMesenchStromOvary_MafB_k-means-cluster#2_top-relative-expression-ranked_1000	COL6A1 CACNA2D1 SGCD PSD3 ADCY2 SVEP1 MICU1 EGFR P3H2	1.09e-04	265	149	9	gudmap_dev gonad_e13.5_F_VascAssocMesenchStromOvary_MafB_k2_1000
CoexpressionAtlas	dev gonad_e13.5_M_InterstitTestis_Sma_top-relative-expression-ranked_1000	GPM6A COL6A1 CACNA2D1 FRAS1 TNC SGCD PSD3 ADAMTS5 ADCY2 SVEP1 EGFR P3H2 P3H1 PAK3 PRKG1 ALDH1A1	1.17e-04	777	149	16	gudmap_dev gonad_e13.5_M_InterstitTestis_Sma_1000
CoexpressionAtlas	FacebaseRNAseq_e10.5_Olfactory Pit_top-relative-expression-ranked_1000_k-means-cluster#2	GPM6A RB1 PSD3 MECOM CHD3 ELOVL2 SORT1 NRXN1 PAK3	1.61e-04	279	149	9	Facebase_RNAseq_e10.5_Olfactory Pit_1000_K2
ToppCell	nucseq-Epithelial\|nucseq / Celltype signatures by Technology, Lineage, Lineage_subclass, Celltype_group, Cell_type2	GPM6A ABCA3 NEBL MECOM GCNT2 EGFR P3H2 RASEF PRKG1 LRBA	1.37e-09	195	151	10	9406866f99555198a9be311fbd65751b70f35446
ToppCell	Control\|World / group, cell type (main and fine annotations)	GPM6A ABCA3 NEBL CYP3A5 MECOM EGFR P3H2 RASEF CACNA2D3	6.38e-09	168	151	9	a3511faf2cd2c2b9c8363c8b99da3f3609c43ed6
ToppCell	356C-Myeloid-Macrophage-FABP4+_Macrophage_3\|Myeloid / Donor, Lineage, Cell class and subclass (all cells)	COL5A1 CACNA2D1 FAT4 ADAMTS5 ELOVL2 SVEP1 VANGL2 MYO3A EGFR	1.01e-08	177	151	9	3d955ea938a1d2fb1b6d68d4997fd454bd632dfc
ToppCell	PCW_07-8.5-Mesenchymal-Mesenchymal_fibroblastic-mes_immature3_(17)\|PCW_07-8.5 / Celltypes from embryonic and fetal-stage human lung	COL5A1 COL6A1 CACNA2D1 NEBL SGCD SVEP1 ADGRG6 EGFR PRKG1	1.62e-08	187	151	9	a9316e2818217ec5feae9cf8816f7249803caee6
ToppCell	Mesenchymal-matrix_fibroblast_1_cell\|World / Lineage, Cell type, age group and donor	COL5A1 COL6A1 CACNA2D1 FAT4 FRAS1 TNC SGCD SVEP1 PRKG1	2.13e-08	193	151	9	acad568621ed677031797b8c2e34dafea798d681
ToppCell	Fetal_29-31_weeks-Mesenchymal-matrix_fibroblast_1_cell\|Fetal_29-31_weeks / Lineage, Cell type, age group and donor	COL5A1 CACNA2D1 FAT4 TNC SGCD CDK14 ADCY2 SVEP1 PRKG1	2.23e-08	194	151	9	011e14d9ed1393275f892060e7708ffadcd0767f
ToppCell	nucseq-Epithelial-Epithelial_Alveolar\|nucseq / Celltype signatures by Technology, Lineage, Lineage_subclass, Celltype_group, Cell_type2	GPM6A ABCA3 NEBL MECOM GCNT2 EGFR P3H2 RASEF PRKG1	2.23e-08	194	151	9	53f3e49e91b1096f3226010e2de767efb490dfe4
ToppCell	COVID-19-lung-Fibroblast\|lung / Disease (COVID-19 only), tissue and cell type	COL5A1 COL6A1 CACNA2D1 FRAS1 NEBL SGCD SVEP1 INPP4B PRKG1	2.66e-08	198	151	9	df3de77216f5c5d6141ec44d01c56b942f611838
ToppCell	Fetal_29-31_weeks-Mesenchymal\|Fetal_29-31_weeks / Lineage, Cell type, age group and donor	COL5A1 COL6A1 CACNA2D1 FAT4 TNC SGCD CDK14 SVEP1 PRKG1	2.66e-08	198	151	9	21cf4d81386761d09d0f6829c01c198e5524176d
ToppCell	ILEUM-inflamed-(8)_Fibroblasts\|inflamed / shred on tissue, inflammation_status, cell class(v3), cell subclass (v2)	COL5A1 COL6A1 FAT4 TNC SGCD PSD3 ADAMTS5 SVEP1 PRKG1	2.77e-08	199	151	9	3a3e2bb21cd0293622b1a975263e918d9ba24265
ToppCell	Children_(3_yrs)-Epithelial-alveolar_epithelial_cell_type_1/2_(AT1/AT2-like)-D046\|Children_(3_yrs) / Lineage, Cell type, age group and donor	GPM6A FRAS1 NEBL MECOM GCNT2 EGFR P3H2 PRKG2	1.41e-07	173	151	8	b799c06a6a5754668e789f70c0c8bc1508568575
ToppCell	356C-Myeloid-Macrophage-FABP4+_Macrophage_3\|Macrophage / Donor, Lineage, Cell class and subclass (all cells)	COL5A1 CACNA2D1 FAT4 ADAMTS5 ELOVL2 SVEP1 VANGL2 MYO3A	1.61e-07	176	151	8	bfa1633e1b7a8a2f04d37fa07284fe9bc0199f46
ToppCell	5'-Parenchyma_lung-Mesenchymal-Mesenchymal_Myocytic-myocytic_fibroblast-Myofibroblasts-Myofibroblasts_L.2.3.2.2\|5' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5	COL6A1 CACNA2D1 FAT4 TNC SGCD HPD PRKG1 PNPLA7	2.00e-07	181	151	8	b116c68393d8836bac080f81a8fcbeb52e0403e7
ToppCell	COVID-19-Heart-Fib_+_EC_+_Pericyte\|COVID-19 / Disease (COVID-19 only), tissue and cell type	COL5A1 COL6A1 TNC MECOM ADAMTS5 SVEP1 PRKG1 FRMD3	2.08e-07	182	151	8	fbd5e332df73bf7141c822fa67b76367dc962017
ToppCell	LPS-IL1RA-Epithelial_alveolar-AT_1-Differentiating_AT2\|LPS-IL1RA / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2	GPM6A FRAS1 ABCA3 ADGRG6 MYO3A FSD1L EGFR CACNA2D3	2.46e-07	186	151	8	4e94158db52df41d71e67b02b9895a358eebee0f
ToppCell	LPS-IL1RA-Epithelial_alveolar-AT_2-Differentiating_AT2\|LPS-IL1RA / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2	SLC46A2 CACNA2D1 ABCA3 FSD1L EGFR P3H2 RASEF CACNA2D3	2.67e-07	188	151	8	4bdf8d49af0e9da349b16e3f012e1b0eec04cc4f
ToppCell	E18.5-samps-Mesenchymal\|E18.5-samps / Age Group, Lineage, Cell class and subclass	COL5A1 COL6A1 CACNA2D1 NEBL TNC ADCY2 SVEP1 ADGRG6	2.78e-07	189	151	8	0c18d3de4720759cf802eefb4d0ddde2a9246a1a
ToppCell	renal_cortex_nuclei-CKD+DKD_normotensive-Mesenchymal-Fibroblast-Collagen-low_Matrisome-low_fibroblast-\|CKD+DKD_normotensive / Celltypes from Cells and Nuclei per compartment and clinical group	COL5A1 CACNA2D1 FAT4 TNC SVEP1 INPP4B EGFR PRKG1	2.89e-07	190	151	8	1121eb607a984c59fbffe7220837fc178745aa55
ToppCell	renal_cortex_nuclei-CKD+DKD_normotensive-Mesenchymal-Fibroblast-Collagen-low_Matrisome-low_fibroblast\|CKD+DKD_normotensive / Celltypes from Cells and Nuclei per compartment and clinical group	COL5A1 CACNA2D1 FAT4 TNC SVEP1 INPP4B EGFR PRKG1	2.89e-07	190	151	8	048b581e3f7ea9fc2f87c0532974bba85c7292c2
ToppCell	LV-01._Fibroblast_I\|World / Chamber and Cluster_Paper	COL5A1 FNDC3B COL6A1 MECOM ADAMTS5 SVEP1 BNIP3L EGFR	2.89e-07	190	151	8	12992ec80a7b4f4f17de693f0719ee061a9918fd
ToppCell	RV-01._Fibroblast_I\|World / Chamber and Cluster_Paper	COL5A1 FNDC3B COL6A1 MECOM ADAMTS5 SVEP1 BNIP3L EGFR	3.01e-07	191	151	8	70c067c54084bfb02c29bab085f4defd477194fb
ToppCell	COVID-19-Heart-Fib_+_EC_+_Pericyte\|Heart / Disease (COVID-19 only), tissue and cell type	COL5A1 COL6A1 TNC MECOM CDK14 SVEP1 EGFR FRMD3	3.13e-07	192	151	8	60b1312e84f6d6448365a952469c506c00b5fe93
ToppCell	droplet-Lung-30m-Mesenchymal-fibroblast-alveolar_fibroblast-alveolar_fibroblast_l49\|30m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype	COL6A1 CACNA2D1 NEBL ADCY2 SVEP1 PRKG1 ALDH1A1 PRKG2	3.13e-07	192	151	8	ff4b728a55c2550c806c47e9ae3d057c35df8464
ToppCell	droplet-Lung-30m-Mesenchymal-fibroblast-alveolar_fibroblast\|30m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype	COL6A1 CACNA2D1 NEBL ADCY2 SVEP1 PRKG1 ALDH1A1 PRKG2	3.13e-07	192	151	8	2d3790bd80a7f214b37094121a2a86ff16362569
ToppCell	LV-01._Fibroblast_I\|LV / Chamber and Cluster_Paper	COL5A1 FNDC3B COL6A1 MECOM ADAMTS5 SVEP1 BNIP3L EGFR	3.26e-07	193	151	8	dc17f3b9758936d428cf17f77a1ce6d4c479b165
ToppCell	RV-02._Fibroblast_II\|RV / Chamber and Cluster_Paper	COL5A1 FNDC3B COL6A1 MECOM ADAMTS5 SVEP1 BNIP3L EGFR	3.39e-07	194	151	8	11c79a8c56ece42713b04b321982e41e239f07a5
ToppCell	Fetal_29-31_weeks-Mesenchymal-matrix_fibroblast_1_cell-D062\|Fetal_29-31_weeks / Lineage, Cell type, age group and donor	COL5A1 CACNA2D1 FRAS1 NEBL SGCD CDK14 SVEP1 PRKG1	3.39e-07	194	151	8	35f132cc38ac133be01834ed0946188aa0757eb4
ToppCell	RV-02._Fibroblast_II\|World / Chamber and Cluster_Paper	COL5A1 FNDC3B COL6A1 MECOM ADAMTS5 SVEP1 BNIP3L EGFR	3.53e-07	195	151	8	ce90b30dcdb56d4cd925cdb79fd9d7cefd998f48
ToppCell	PCW_13-14-Mesenchymal-Mesenchymal_fibroblastic\|PCW_13-14 / Celltypes from embryonic and fetal-stage human lung	COL5A1 COL6A1 CACNA2D1 FAT4 SGCD CDK14 SVEP1 PRKG1	3.67e-07	196	151	8	1450cb69c5bf469e97c03bf1890f6f7c54165b8a
ToppCell	renal_medulla_nuclei-Adult_normal_reference-Epithelial\|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group	FRAS1 NEBL TMEM116 MECOM P3H2 MYO3B LRBA CACNA2D3	3.67e-07	196	151	8	eea66711a16134f86e6c533a5a837ff2e0d7ca7f
ToppCell	COVID-19-Fibroblasts-Intermediate_pathological_FB\|COVID-19 / group, cell type (main and fine annotations)	COL5A1 COL6A1 CACNA2D1 NEBL TNC SGCD SVEP1 PRKG1	3.81e-07	197	151	8	f1c8936986123a3151140c374fcd62d6705c530b
ToppCell	PCW_13-14-Mesenchymal\|PCW_13-14 / Celltypes from embryonic and fetal-stage human lung	COL5A1 COL6A1 CACNA2D1 FAT4 SGCD CDK14 SVEP1 PRKG1	3.81e-07	197	151	8	73a2085d2682d636726a5432d572ae2a3fbe1c3f
ToppCell	AT2_cells-SSc-ILD_01\|World / lung cells shred on cell class, cell subclass, sample id	SLC46A2 SELENOW ABCA3 TNC CHD3 P3H2 PAK3 SLC6A14	3.81e-07	197	151	8	42e49a8ce3118db6c2fd620d70c480b75143c828
ToppCell	BAL-Severe-Epithelial-Epithelial-AT1/AT2-\|Severe / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.01)	ABCA3 TNC ADGRG6 HOXD1 EGFR P3H2 RASEF SLC6A14	3.96e-07	198	151	8	691a2f1779225e5519155460eeb6a2aac5f67a92
ToppCell	PCW_10-12-Mesenchymal-Mesenchymal_fibroblastic\|PCW_10-12 / Celltypes from embryonic and fetal-stage human lung	COL5A1 COL6A1 CACNA2D1 FAT4 SGCD CDK14 SVEP1 PRKG1	3.96e-07	198	151	8	17dc055e2a289496d9c5cdbf3297bdf906dc6d22
ToppCell	background-Hepatic_Stellate_cells\|World / Sample and Cell Type and Tumor Cluster (all cells)	COL5A1 COL6A1 CACNA2D1 TNC SVEP1 INPP4B HPD PRKG1	3.96e-07	198	151	8	79f32f965aed6a10c5cb803173e3db7b32e07a91
ToppCell	(5)_Fibroblasts-(5)_Fibroblast-B_(Myofibroblast)\|(5)_Fibroblasts / Lung cell shreds - cell class (v4) and cell subclass (v4)	COL5A1 CMTM3 TNC SGCD PSD3 CHD3 ADGRG6 P3H1	3.96e-07	198	151	8	196257c4420ac801ed9fbb444f11718adb7560ae
ToppCell	BAL-Severe-Epithelial-Epithelial-AT1/AT2\|Severe / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.01)	ABCA3 TNC ADGRG6 HOXD1 EGFR P3H2 RASEF SLC6A14	3.96e-07	198	151	8	aed0476248e9637897eefb1623ec4035f2dacd82
ToppCell	BAL-Severe-Epithelial-Epithelial-AT1/AT2\|Severe / Location, Disease Group, Cell group, Cell class (2021.03.09)	ABCA3 TNC ADGRG6 HOXD1 EGFR P3H2 RASEF SLC6A14	3.96e-07	198	151	8	e115eea04012e9e492e923ed080e1723c38d14fd
ToppCell	BAL-Severe-Epithelial-Epithelial-AT1/AT2-\|Severe / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.09)	ABCA3 TNC ADGRG6 HOXD1 EGFR P3H2 RASEF SLC6A14	3.96e-07	198	151	8	33d1e0b6f57663544bee0ffdde83a65da764d44c
ToppCell	Severe_COVID-19-Epithelial-AT1/AT2\|Severe_COVID-19 / Disease group,lineage and cell class （2021.01.30）	ABCA3 TNC ADGRG6 HOXD1 EGFR P3H2 RASEF SLC6A14	3.96e-07	198	151	8	43e33d28d9de5033bd00d39be953542a225236ed
ToppCell	background-Hepatic_Stellate_cells\|background / Sample and Cell Type and Tumor Cluster (all cells)	COL5A1 COL6A1 CACNA2D1 TNC SGCD SVEP1 INPP4B PRKG1	3.96e-07	198	151	8	bd11b0e9e80449aab979a02c1023e0638c431c7c
ToppCell	mLN-B_cell-B_cell_IgA_Plasma\|B_cell / Region, Cell class and subclass	FNDC3B NEBL TNC CDKL4 INPP4B SLC6A9 MYO3B CACNA2D3	4.11e-07	199	151	8	09494953bc7fff63cf2763ea89fca7abb97c186f
ToppCell	Mesenchymal\|World / Lineage, Cell type, age group and donor	COL5A1 COL6A1 CACNA2D1 FAT4 TNC SGCD SVEP1 PRKG1	4.11e-07	199	151	8	4bac110c2b3609f6ee5d0e3275da0824a6240270
ToppCell	ILEUM-non-inflamed-(8)_Fibroblasts\|non-inflamed / shred on tissue, inflammation_status, cell class(v3), cell subclass (v2)	COL5A1 COL6A1 TNC SGCD PSD3 ADAMTS5 SVEP1 PRKG1	4.11e-07	199	151	8	d9d7f36b4b5592b7855448730044c90997b55499
ToppCell	PCW_10-12-Mesenchymal\|PCW_10-12 / Celltypes from embryonic and fetal-stage human lung	COL5A1 COL6A1 CACNA2D1 FAT4 SGCD CDK14 SVEP1 PRKG1	4.11e-07	199	151	8	a09292de4c4447b8eee55d401808e43b817321cc
ToppCell	LPS_IL1RA_TNF-Mesenchymal_fibroblastic-Fibroblasts-MatrixFB\|LPS_IL1RA_TNF / Treatment groups by lineage, cell group, cell type	COL5A1 COL6A1 TNC PSD3 CDK14 SVEP1 PRKG1 ALDH1A1	4.11e-07	199	151	8	30d3e8c0681ec11f86dd38c5f48d21187a1b4f90
ToppCell	Tracheal-NucSeq-Stromal-Fibroblastic-Fibro_peribronchial\|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations	COL5A1 COL6A1 FAT4 SGCD SVEP1 MYO3B PRKG1 CACNA2D3	4.27e-07	200	151	8	58b38f9a484ee94191091a0659ed62ebed2d4a14
ToppCell	10x_3'_v3-blood_(10x_3'_v3)-hematologic-hematopoietic_progenitor-hematopoietic_stem_cell\|blood_(10x_3'_v3) / Per Platform+tissue_group, by lineage_subgroup, cell_group, cell_type	MORC1 COL5A1 MECOM ADGRG6 PRKG1 ALDH1A1 PRKG2	1.90e-06	170	151	7	5bb577e2c4bd275fbe4ee23ff8c007b2fcb90e56
ToppCell	nucseq-Mesenchymal-Fibroblastic-Fibroblastic_2-ASMC\|nucseq / Celltype signatures by Technology, Lineage, Lineage_subclass, Celltype_group, Cell_type2	COL6A1 CACNA2D1 MYOM1 SGCD INPP4B PRKG1 CACNA2D3	2.13e-06	173	151	7	cb6389536195443633adb06e5f1b7483530773d1
ToppCell	Adult-Epithelial-basal_cell-D231\|Adult / Lineage, Cell type, age group and donor	FRAS1 ABCA12 PSD3 ADGRG6 MYO3A EGFR SLC4A11	2.21e-06	174	151	7	a4f98afe7d1cc2617f6f7bc8092c41df57474b30
ToppCell	COVID-19-Heart-CM_3\|COVID-19 / Disease (COVID-19 only), tissue and cell type	CACNA2D1 MYOM1 NEBL SGCD SPTB INPP4B SORT1	2.39e-06	176	151	7	9df7a124ebafb0087da0cda133a394275d7bed81
ToppCell	COVID-19-Epithelial_cells-AT1\|COVID-19 / group, cell type (main and fine annotations)	GPM6A NEBL MECOM GCNT2 EGFR P3H2 RASEF	2.67e-06	179	151	7	a0b33bd69ffdfd5d38d80207fb40058a490aa19e
ToppCell	Children_(3_yrs)-Epithelial-alveolar_epithelial_cell_type_1/2_(AT1/AT2-like)\|Children_(3_yrs) / Lineage, Cell type, age group and donor	GPM6A FRAS1 NEBL MECOM GCNT2 EGFR PRKG2	2.67e-06	179	151	7	cb38b54261a7af5ee3347e64c8aa880a77ed0763
ToppCell	renal_medulla_nuclei-Renal_AKI_(acute_kidney_injury)-Epithelial-Distal_tubule_epithelial_cell-kidney_loop_of_Henle_thick_ascending_limb_epithelial_cell-Medullary_Thick_Ascending_Limb_Cell\|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group	NAIP MECOM GCNT2 SGK2 MYO3B LRBA CACNA2D3	2.77e-06	180	151	7	9e09b3dfe344b5d50520711513d389865d73a861
ToppCell	COVID-19-Epithelial_cells-AT2\|COVID-19 / group, cell type (main and fine annotations)	ABCA3 NEBL MECOM EGFR P3H2 RASEF SLC6A14	3.21e-06	184	151	7	369b82f793deab672204558ae4e112cfa5aa9ccc
ToppCell	COVID-19-Heart-CM_2\|COVID-19 / Disease (COVID-19 only), tissue and cell type	CACNA2D1 MYOM1 NEBL SGCD SPTB PSD3 INPP4B	3.32e-06	185	151	7	549eeb521c3985bff396ea0f202db21822efa51f
ToppCell	droplet-Liver-LIVER_HEP-30m-Mesenchymal\|Liver / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation	COL5A1 COL6A1 CACNA2D1 TNC SGCD NRXN1 PRKG1	3.32e-06	185	151	7	f814ec9d4ade717a0109398e9768d0d66f09317b
ToppCell	IPF-Epithelial-ATII\|IPF / Disease state, Lineage and Cell class	ABCA3 NEBL MECOM P3H2 RASEF PRKG1 SLC6A14	3.32e-06	185	151	7	563b4e6d92bb5d77a3829556116a8e99aebac615
ToppCell	COVID-19-Heart-Fib_2\|COVID-19 / Disease (COVID-19 only), tissue and cell type	COL5A1 COL6A1 CACNA2D1 TNC ADAMTS5 SVEP1 PRKG1	3.32e-06	185	151	7	8f95d8e591bf7379d13f5a0545b0cb49e2b1ab5d
ToppCell	droplet-Liver-LIVER_HEP-30m-Mesenchymal-hepatic_stellate_cell\|Liver / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation	COL5A1 COL6A1 CACNA2D1 TNC SGCD NRXN1 PRKG1	3.32e-06	185	151	7	40e958511790e84321da5ccf735f9974c06a0263
ToppCell	droplet-Liver-LIVER_HEP-30m-Mesenchymal-hepatic_stellate_cell\|Liver / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation	COL5A1 COL6A1 CACNA2D1 TNC SGCD NRXN1 PRKG1	3.32e-06	185	151	7	5f2eeba80aff145e85cfd81e2890a155406badb9
ToppCell	IPF-Epithelial-ATII\|World / Disease state, Lineage and Cell class	ABCA3 NEBL MECOM P3H2 RASEF PRKG1 SLC6A14	3.44e-06	186	151	7	6a4ff2da0af0f5e590d9f9daa5b5e9ac8c868947
ToppCell	human_hepatoblastoma-Hepatic_Stellate_cells\|World / Sample and Cell Type and Tumor Cluster (all cells)	COL5A1 CACNA2D1 TNC CDK14 INPP4B PRKG1 FRMD3	3.44e-06	186	151	7	cb1fc4b9140666b43415e21c9b434dc9b144e9d0
ToppCell	Adult-Mesenchymal-matrix_fibroblast_1_cell-D175\|Adult / Lineage, Cell type, age group and donor	COL5A1 COL6A1 CACNA2D1 TNC SGCD SVEP1 PRKG1	3.57e-06	187	151	7	e15d2967aac248da3517bc2c7d1beaa1d5a0aa7f
ToppCell	Control-Fibroblasts-Other_FB\|Control / group, cell type (main and fine annotations)	COL5A1 COL6A1 CACNA2D1 FAT4 SGCD SVEP1 PRKG1	3.57e-06	187	151	7	bd3739c4a52aa1ba5deffd778e113a9800f7e158
ToppCell	COPD-Epithelial-ATII\|COPD / Disease state, Lineage and Cell class	ABCA3 NEBL TNC P3H2 RASEF PRKG1 SLC6A14	3.69e-06	188	151	7	eb6d79d733b53f64ca615bb777c64ed456866549
ToppCell	Mesenchymal-myofibroblast_cell\|World / Lineage, Cell type, age group and donor	COL5A1 COL6A1 CACNA2D1 FAT4 TNC ADAMTS5 ADGRG6	3.83e-06	189	151	7	44e37f88137bb249933eb615235b2cf2ae7f3925
ToppCell	LPS-antiTNF-Stromal_mesenchymal-Lung_smooth_muscle\|LPS-antiTNF / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2	CACNA2D1 TNC SGCD ADAMTS5 ADGRG6 PAK3 PRKG1	3.83e-06	189	151	7	7ab1cfc1657277858339f7258a0c4ae9cb42fdf8
ToppCell	5'-Parenchyma_lung-Epithelial-Alveolar_epithelium-type_II_pneumocyte-AT2-AT2_L.0.1.3.2\|5' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5	SLC46A2 ABCA3 CYP3A5 TNC HOXD1 P3H2 SLC6A14	3.83e-06	189	151	7	da014519d6eb21bc2dc2ed65eafe638b42a068ed
ToppCell	PCW_07-8.5-Epithelial-Epithelial_airway-epi_proximal_progenitor1_(6)\|PCW_07-8.5 / Celltypes from embryonic and fetal-stage human lung	FRAS1 GCNT2 P3H2 MYO3B RASEF FRMD3 SORL1	3.83e-06	189	151	7	7659c7bbd58ee959a159294fb8d17317bbcc5681
ToppCell	renal_cortex_nuclei-Adult_normal_reference\|renal_cortex_nuclei / Celltypes from Cells and Nuclei per compartment and clinical group	FRAS1 CYP3A5 FNDC3A BNIP3L EGFR P3H2 SAFB2	3.83e-06	189	151	7	a48df46274d51e84ffb40264646de7346104efb9
ToppCell	LPS_only-Stromal_mesenchymal-Matrix_Fibroblast-MatrixFB\|LPS_only / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2	COL5A1 COL6A1 TNC CDK14 SVEP1 PRKG1 FRMD3	3.83e-06	189	151	7	2a22b9fae70afb3dab8476f9c00e48a4df756410
ToppCell	Control-Epithelial-ATII\|Control / Disease state, Lineage and Cell class	ABCA3 NEBL EGFR P3H2 RASEF PRKG1 SLC6A14	3.96e-06	190	151	7	d50902a3abcc18aafa36d83cc2c6e07d7f7cb197
ToppCell	PCW_07-8.5-Epithelial-Epithelial_airway-epi_proximal_secretory_(0)\|PCW_07-8.5 / Celltypes from embryonic and fetal-stage human lung	FRAS1 GCNT2 ADCY2 P3H2 MYO3B RASEF FRMD3	4.10e-06	191	151	7	60ff989fe99d243a3d52955223680cdd1f1917a4
ToppCell	droplet-Lung-30m-Mesenchymal-fibroblast\|30m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype	COL5A1 COL6A1 NEBL ADAMTS5 SVEP1 ALDH1A1 PRKG2	4.10e-06	191	151	7	cd497abed9e00e4e0becd9dbc036c6e7a60ae791
ToppCell	LV-02._Fibroblast_II\|World / Chamber and Cluster_Paper	FNDC3B COL6A1 MECOM ADAMTS5 SVEP1 BNIP3L EGFR	4.10e-06	191	151	7	d36565257ccba8c1bbed2c1c01be66a9cbb5f834
ToppCell	Children_(3_yrs)-Epithelial\|Children_(3_yrs) / Lineage, Cell type, age group and donor	GPM6A ABCA3 NEBL MECOM GCNT2 EGFR P3H2	4.10e-06	191	151	7	e432c6e1ae82dddf84314ce73d2b7a991630d905
ToppCell	nucseq-Mesenchymal-Fibroblastic-Fibroblastic_2-AF1\|nucseq / Celltype signatures by Technology, Lineage, Lineage_subclass, Celltype_group, Cell_type2	COL5A1 COL6A1 FAT4 FRAS1 SGCD SVEP1 PRKG1	4.10e-06	191	151	7	6688cee34beee4f151ac17fccbc9c26a9aad72e1
ToppCell	Control-Multiplet-Multiplet\|World / Disease state, Lineage and Cell class	ABCA3 NEBL EGFR P3H2 RASEF PRKG1 SLC6A14	4.24e-06	192	151	7	1bfd022d5b87cf8a5d5069f559339a553a52a0a2
ToppCell	facs-Heart-LV-3m-Mesenchymal-fibroblast_of_cardiac_tissue\|Heart / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation	COL5A1 FNDC3B COL6A1 ADAMTS5 SVEP1 EGFR ALDH1A1	4.24e-06	192	151	7	671d4e1eee5aba03c43dbc98f4b51ce42b3df5d5
ToppCell	Epithelial\|World / Lineage, Cell type, age group and donor	GPM6A ABCA3 NEBL MECOM GCNT2 EGFR P3H2	4.24e-06	192	151	7	499e8893afea5e6d3371e0bd018f7e86a524d669
ToppCell	RV-01._Fibroblast_I\|RV / Chamber and Cluster_Paper	COL5A1 COL6A1 MECOM ADAMTS5 SVEP1 BNIP3L EGFR	4.24e-06	192	151	7	356160b113c3305a61ceeaff33ce3c9da0be2878
ToppCell	Fetal_29-31_weeks-Epithelial-alveolar_epithelial_cell_type_1/2_(AT1/AT2-like)-D062\|Fetal_29-31_weeks / Lineage, Cell type, age group and donor	GPM6A ABCA3 NEBL MECOM GCNT2 P3H2 PRKG2	4.24e-06	192	151	7	29f49f00770c991b5f27e4cb701dd2d2d6cb7178
ToppCell	nucseq-Mesenchymal-Fibroblastic-Fibroblastic_2\|nucseq / Celltype signatures by Technology, Lineage, Lineage_subclass, Celltype_group, Cell_type2	COL5A1 COL6A1 FRAS1 SGCD SVEP1 INPP4B PRKG1	4.24e-06	192	151	7	99ce9e3c4c50cf64ebb62145f2b5420efa0db309
ToppCell	droplet-Lung-30m-Mesenchymal\|30m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype	COL5A1 COL6A1 CACNA2D1 NEBL ADCY2 SVEP1 ALDH1A1	4.24e-06	192	151	7	5d5bec238b196f0b3e727fd94f078d6ae524cb01
ToppCell	Adult-Epithelial\|Adult / Lineage, Cell type, age group and donor	ABCA3 NEBL MECOM GCNT2 EGFR P3H2 PRKG1	4.24e-06	192	151	7	efb962a5fd3b9bdfd8cf8d13c435e29c8271713e
ToppCell	facs-Heart-LV-3m-Mesenchymal-fibroblast_of_cardiac_tissue\|Heart / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation	COL5A1 FNDC3B COL6A1 ADAMTS5 SVEP1 EGFR ALDH1A1	4.24e-06	192	151	7	840a34c1b82d218be999ab5e1bcafd6370d7a4b1
ToppCell	PND28-Mesenchymal-Mesenchymal_structural-Fibroblastic-AF1-AF1_mature\|PND28 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif	COL6A1 CACNA2D1 NEBL TNC SVEP1 ALDH1A1 PRKG2	4.39e-06	193	151	7	4c74a3f69b2cbdf139e7e66b44bd86869ac34dc0
ToppCell	PND28-Mesenchymal-Mesenchymal_structural-Fibroblastic-AF1\|PND28 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif	COL6A1 CACNA2D1 NEBL TNC SVEP1 ALDH1A1 PRKG2	4.39e-06	193	151	7	ff8ceeb3cfd1bef7239df490c19d181091750833
ToppCell	LPS-IL1RA+antiTNF-Stromal_mesenchymal-Matrix_Fibroblast-MatrixFB\|LPS-IL1RA+antiTNF / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2	COL5A1 COL6A1 TNC SGCD PSD3 SVEP1 PRKG1	4.39e-06	193	151	7	fb28717fadd06c3840636d25409ce80c9254bd34
ToppCell	LV-02._Fibroblast_II\|LV / Chamber and Cluster_Paper	FNDC3B COL6A1 MECOM ADAMTS5 SVEP1 BNIP3L EGFR	4.54e-06	194	151	7	014d2feb5db2a6a35ef759761a41e466e108c3c1
ToppCell	PCW_07-8.5-Epithelial-Epithelial_airway\|PCW_07-8.5 / Celltypes from embryonic and fetal-stage human lung	FRAS1 GCNT2 ADCY2 P3H2 MYO3B RASEF FRMD3	4.54e-06	194	151	7	f95c8dc242c9aebcadfe61b1ed033349cb7e5a88
ToppCell	COVID-19-Heart-Fib_1\|Heart / Disease (COVID-19 only), tissue and cell type	COL5A1 FNDC3B COL6A1 ADAMTS5 SVEP1 EGFR PRKG1	4.70e-06	195	151	7	f423baa36ac7cdc383c033e35a7d17e6bf913323
ToppCell	PCW_10-12-Mesenchymal-Mesenchymal_fibroblastic-mes_immature3_(17)\|PCW_10-12 / Celltypes from embryonic and fetal-stage human lung	COL5A1 COL6A1 CACNA2D1 FAT4 SVEP1 ADGRG6 PRKG1	4.70e-06	195	151	7	1cdf5f296029ae424d9dba42e86a6d111e4896e6
ToppCell	PCW_10-12-Mesenchymal-Mesenchymal_fibroblastic-mes_immature5_(6)\|PCW_10-12 / Celltypes from embryonic and fetal-stage human lung	CACNA2D1 FAT4 NEBL PSD3 ADGRG6 EGFR PRKG1	4.70e-06	195	151	7	0e55fa5b3cbeb7baee3d4ac272a3bf80381ec937
ToppCell	renal_medulla_nuclei-CKD+DKD_normotensive-Epithelial\|CKD+DKD_normotensive / Celltypes from Cells and Nuclei per compartment and clinical group	FRAS1 NEBL MECOM GCNT2 MYO3B LRBA CACNA2D3	4.70e-06	195	151	7	6477e6e7be5bd8eb99119a12ae16334ccddecd43
ToppCell	COVID-19-Fibroblasts-Alveolar_FB\|COVID-19 / group, cell type (main and fine annotations)	COL5A1 FRAS1 NEBL SGCD SVEP1 INPP4B PRKG1	4.70e-06	195	151	7	603050beeb33c331d4b2e3fa46cae3f3e0e4bdc7
ToppCell	Adult-Mesenchymal-matrix_fibroblast_1_cell-D122\|Adult / Lineage, Cell type, age group and donor	COL5A1 COL6A1 SGCD SVEP1 PRKG1 ALDH1A1 CACNA2D3	4.70e-06	195	151	7	aa0add081881d349099d12efca5cdee098038d4e
ToppCell	PCW_05-06-Mesenchymal\|PCW_05-06 / Celltypes from embryonic and fetal-stage human lung	COL5A1 COL6A1 FAT4 SGCD CDK14 SVEP1 PRKG1	4.86e-06	196	151	7	dca52c57ba35d9395cdbca8b881f12ece721b10f
Drug	Vitamin K 3	ATXN2L SELENOW CMTM3 RB1 TNC WDR81 SRPK1 FNDC3A GDI1 SQOR GDI2 SGK2 WDR3 HOXD1 EGFR TECPR2 FIBP EIF3C ALDH1A1 TMED10 TOP2A TOP2B SLC6A14 SORL1 DYRK2	6.29e-07	1249	150	25	ctd:D024483
Drug	N'-hydroxyformamidine	CYP3A5 PRKG1 PRKG2	1.12e-06	4	150	3	CID000012227
Drug	4-(N-methyl-N-nitrosamino)-1-(3-pyridyl)-1-butanone	CDK16 COL6A1 SELENOW RB1 CYP3A5 RPS7 EGFR DHRS7 ALDH1A1 ABCC2 TOP2A	3.81e-06	291	150	11	ctd:C016583
Drug	verapamil	CACNA2D1 ABCA3 CYP3A5 ABCA12 GCNT2 BIRC6 ADCY2 CFHR4 MYO3A EGFR MYO3B ABCC2 TOP2B CACNA2D3	4.72e-06	490	150	14	CID000002520
Drug	Promazine hydrochloride [53-60-1]; Up 200; 12.4uM; MCF7; HT_HG-U133A	ATXN2L CDK18 FAT4 RB1 KDM5A CYP3A5 SPTB GCNT2 PRKG2	5.11e-06	191	150	9	6028_UP
Drug	Docetaxel trihydrate	COL5A1 CYP3A5 NAIP CROT EGFR TMBIM4 UMPS TUBA4B TOP2B	8.04e-06	202	150	9	CID000003143
Drug	chlorotrianisene	CYP3A5 SAFB SAFB2 PRKG2	9.93e-06	21	150	4	CID000011289
Drug	arabinosyladenine	GPM6A COL5A1 CACNA2D1 ABCA12 SRPK1 FNDC3A PRDX2 IDH3B MDH1 ADCY2 AK7 ADORA3 UMPS PRKG1 PRKG2 LRBA ABCC2	1.18e-05	762	150	17	CID000000191
Drug	Pp55	RB1 NCL CSNK1A1L EGFR CSNK1A1	1.94e-05	50	150	5	CID000132900
Drug	lithium dimer	ABCA3 ABCA12 TGM1 BNIP3L	2.42e-05	26	150	4	CID000139759
Drug	nitroxyl	MORC1 RB1 CYP3A5 BIRC6 HPD PRKG1 PRKG2 DYRK2	3.22e-05	185	150	8	CID000000945
Drug	AC1L1IZ2	SRPK1 AK7 ADORA3 MYO3A EGFR MYO3B TUBA4B PRKG1 LRBA TOP2B	3.50e-05	304	150	10	CID000004795
Drug	Trichostatin A, from Streptomyces sp.; Up 200; 0.1uM; HL60; HT_HG-U133A	COL6A1 MECOM PRDX2 LY96 INPP4B BNIP3L TECPR2 ABCC2	3.61e-05	188	150	8	2370_UP
Drug	Pro 46Ae	PRDX2 HPD UMPS SORL1	3.78e-05	29	150	4	CID005485153
Drug	GTP - Na	CDK9 CACNA2D1 RPS7 COPB2 MDH1 GDI2 ADCY2 TGM1 ADORA3 GTF2F1 CSNK1A1L EGFR HPD CSNK1A1 TUBA4B EIF3C PRKG1 PRKG2	3.85e-05	923	150	18	CID000000762
Drug	acetonitrile anion	ABCA12 TGM1	4.31e-05	2	150	2	CID003015105
Drug	Dexrazoxane	TOP2A TOP2B	4.31e-05	2	150	2	DB00380
Drug	F14512	TOP2A TOP2B	4.31e-05	2	150	2	ctd:C534191
Drug	Daunorubicin	TOP2A TOP2B	4.31e-05	2	150	2	DB00694
Drug	Finasteride [98319-26-7]; Up 200; 10.8uM; MCF7; HT_HG-U133A	GPM6A RB1 CYP3A5 ASAP3 ELOVL2 SGK2 TECPR2 PRKG2	4.51e-05	194	150	8	3641_UP
Drug	genistein	ATXN2L CACNA2D1 HNRNPCL1 CYP3A5 FNDC3A HNRNPC INPP4B CFHR4 GTF2F1 CROT SAFB EGFR SAFB2 TUBA4B PRKG1 PRKG2 LRBA ABCC2 TOP2B CACNA2D3	4.63e-05	1117	150	20	CID005280961
Drug	Ursolic acid [77-52-1]; Down 200; 8.8uM; PC3; HT_HG-U133A	CDK16 NEBL KDM5A SAFB TECPR2 P3H2 SAFB2 DYRK2	4.67e-05	195	150	8	5825_DN
Drug	Chlorogenic acid [327-97-9]; Down 200; 11.2uM; PC3; HT_HG-U133A	COL6A1 NEBL TNC ASAP3 MECOM FNDC3A SLC6A9 SAFB2	5.02e-05	197	150	8	4024_DN
Drug	Ticarcillin sodium [4697-14-7]; Up 200; 9.4uM; PC3; HT_HG-U133A	COL5A1 COL6A1 FAT4 CYP3A5 TNC GCNT2 SGK2 PAK3	5.21e-05	198	150	8	5829_UP
Drug	Clemizole hydrochloride [1163-36-6]; Up 200; 11uM; MCF7; HT_HG-U133A	MORC1 ATXN2L COL6A1 SGCD ADAMTS5 SVEP1 SLC6A9 SAFB2	5.21e-05	198	150	8	4695_UP
Drug	Pinacidil [85371-64-8]; Up 200; 16.4uM; PC3; HT_HG-U133A	CDK9 MECOM ZZEF1 SLC6A9 SAFB2 IFT122 PRRC2B DYRK2	5.21e-05	198	150	8	6356_UP
Drug	imidazolidinone	ABCA12 SGCD BNIP3L	5.90e-05	12	150	3	CID000008453
Drug	Taxane	COL5A1 CROT EGFR UMPS TUBA4B ABCC2	6.25e-05	103	150	6	CID000108169
Disease	Adrenocortical carcinoma	RB1 BAP1 EGFR TOP2A	1.62e-06	18	145	4	C0206686
Disease	Congenital Nonbullous Ichthyosiform Erythroderma	ABCA12 LIPN TGM1	1.86e-05	11	145	3	C0079154
Disease	Congenital ichthyosis of skin	ABCA12 LIPN TGM1	1.86e-05	11	145	3	cv:C0020758
Disease	B cell deficiency (implicated_via_orthology)	TOP2A TOP2B	2.40e-05	2	145	2	DOID:2115 (implicated_via_orthology)
Disease	outer ear morphology trait	ADGRG6 MYO3B LRBA	2.48e-05	12	145	3	EFO_0007664
Disease	Neoplasm of uncertain or unknown behavior of breast	RB1 INPP4B BAP1 BTK	4.92e-05	41	145	4	C0496956
Disease	Breast adenocarcinoma	RB1 INPP4B BAP1 BTK	4.92e-05	41	145	4	C0858252
Disease	Malignant neoplasm of breast	FNDC3B ABCA3 RB1 RPS7 MECOM INPP4B BAP1 EGFR P3H2 TLE3 BTK SLC6A5 UMPS LRBA TOP2A SORL1	8.09e-05	1074	145	16	C0006142
Disease	Myeloid Leukemia	MECOM PRDX2 TOP2B	8.98e-05	18	145	3	C0023470
Disease	Leukemia, Monocytic, Chronic	MECOM PRDX2 TOP2B	8.98e-05	18	145	3	C0023466
Disease	Squamous cell carcinoma of esophagus	FAT4 RB1 GDI2 EGFR ABCC2	1.09e-04	95	145	5	C0279626
Disease	Ichthyosis Congenita I	ABCA12 TGM1	1.43e-04	4	145	2	C4551630
Disease	Harlequin Fetus	ABCA12 TGM1	1.43e-04	4	145	2	C0239849
Disease	chondroitin sulfate N-acetylgalactosaminyltransferase 2 measurement	RPS7 CSGALNACT2	1.43e-04	4	145	2	EFO_0801473
Disease	4-hydroxyphenylpyruvate measurement	CFAP251 HPD	1.43e-04	4	145	2	EFO_0800120
Disease	Ichthyosis Congenita II	ABCA12 TGM1	1.43e-04	4	145	2	C3536797
Disease	autosomal recessive congenital ichthyosis 1 (is_implicated_in)	ABCA12 TGM1	1.43e-04	4	145	2	DOID:0060656 (is_implicated_in)
Disease	Collodion Fetus	ABCA12 TGM1	1.43e-04	4	145	2	C3543867
Disease	Congenital ichthyosis	ABCA12 TGM1	2.38e-04	5	145	2	C0020758
Disease	Sezary Syndrome	RB1 CHD3 PRKG1	3.12e-04	27	145	3	C0036920
Disease	Breast Carcinoma	RB1 RPS7 MECOM INPP4B BAP1 EGFR TLE3 BTK UMPS TOP2A	3.43e-04	538	145	10	C0678222
Disease	Colorectal Neoplasms	ABCA3 ABCA12 LY96 HOXD1 EGFR UMPS ABCC2	4.57e-04	277	145	7	C0009404
Disease	Liver Cirrhosis, Experimental	COL5A1 COL6A1 SELENOW CMTM3 LY96 MDH1 SGK2 ADORA3 CROT DHRS7 ALDH1A1 ABCC2	4.58e-04	774	145	12	C0023893
Disease	Ovarian Mucinous Adenocarcinoma	CDK14 SBK1 MYO3A	4.72e-04	31	145	3	C1335167
Disease	electroencephalogram measurement	FNDC3B SGCD MYO3A PRKG2	4.93e-04	74	145	4	EFO_0004357
Disease	syndromic X-linked intellectual disability Najm type (implicated_via_orthology)	CSNK1A1L CSNK1A1	4.96e-04	7	145	2	DOID:0060807 (implicated_via_orthology)
Disease	microcephaly (implicated_via_orthology)	COPB2 WDR81 ETNK1	5.19e-04	32	145	3	DOID:10907 (implicated_via_orthology)
Disease	Chloracne	TGM1 EGFR FRMD3	5.69e-04	33	145	3	C0263454
Disease	chronic obstructive pulmonary disease	FNDC3B FRAS1 ABCA3 NEBL MECOM ADGRG6 CSNK1A1 DMWD DTHD1 TOP2B CACNA2D3	6.16e-04	688	145	11	EFO_0000341
Disease	Hereditary spherocytosis	SPTB UMPS	6.59e-04	8	145	2	C0037889
Disease	2-hydroxyphenylacetate measurement	CFAP251 HPD	6.59e-04	8	145	2	EFO_0800131
Disease	Congenital Hydrocephalus	WDR81 IFT122	6.59e-04	8	145	2	C0020256
Disease	Attached earlobe	ADGRG6 MYO3B	6.59e-04	8	145	2	HP_0009907
Disease	Colorectal Carcinoma	ABCA3 ABCA12 ASAP3 LY96 ADORA3 CSNK1A1L HOXD1 EGFR UMPS ABCC2 SORL1	7.26e-04	702	145	11	C0009402
Disease	neurodegenerative disease (implicated_via_orthology)	FAT4 MTMR12 NPLOC4 MICU1 PNPLA7	7.67e-04	145	145	5	DOID:1289 (implicated_via_orthology)
Disease	coronary artery disease	CDK18 FNDC3B FAT4 SGCD RPS7 PSD3 MECOM HNRNPC SVEP1 SBK1 NRXN1 UMPS PRKG1 TMED10 MTCH1	8.19e-04	1194	145	15	EFO_0001645
Disease	Cancer of Nasopharynx	MECOM EGFR	8.44e-04	9	145	2	C0238301
Disease	Nasopharyngeal Neoplasms	MECOM EGFR	8.44e-04	9	145	2	C0027439
Disease	Colonic Neoplasms	CACNA2D1 MECOM BAP1 EGFR UMPS	9.48e-04	152	145	5	C0009375
Disease	protein eva-1 homolog C measurement	TNC RPS7	1.05e-03	10	145	2	EFO_0801942
Disease	FEV/FEC ratio	FNDC3B FRAS1 ABCA3 NEBL MECOM ADAMTS5 ADCY2 NPLOC4 INPP4B ADGRG6 TTC7B DTHD1 TOP2B CACNA2D3 SORL1	1.08e-03	1228	145	15	EFO_0004713
Disease	Malignant tumor of colon	CACNA2D1 MECOM BAP1 EGFR UMPS	1.16e-03	159	145	5	C0007102
Disease	eosinophilic esophagitis	NEBL INO80C NRXN1 PRKG1 MTCH1	1.29e-03	163	145	5	EFO_0004232
Disease	Carcinomatosis	COL5A1 RB1 PRDX2 LY96 EGFR	1.29e-03	163	145	5	C0205699
Disease	Carcinoma, Spindle-Cell	COL5A1 RB1 PRDX2 LY96 EGFR	1.29e-03	163	145	5	C0205697
Disease	Undifferentiated carcinoma	COL5A1 RB1 PRDX2 LY96 EGFR	1.29e-03	163	145	5	C0205698
Disease	Anaplastic carcinoma	COL5A1 RB1 PRDX2 LY96 EGFR	1.29e-03	163	145	5	C0205696
Disease	Carcinoma	COL5A1 RB1 PRDX2 LY96 EGFR	1.33e-03	164	145	5	C0007097
Disease	platelet aggregation	TSSK2 HNRNPC CACNA2D3	1.42e-03	45	145	3	GO_0070527
Disease	acute myeloid leukemia (implicated_via_orthology)	TOP2A TOP2B	1.53e-03	12	145	2	DOID:9119 (implicated_via_orthology)
Disease	Osteosarcoma	RB1 PRDX2 EGFR	1.61e-03	47	145	3	C0029463
Disease	Abnormality of refraction	COL5A1 FNDC3B COL6A1 NEBL KDM5A ZZEF1 BIRC6 NPLOC4 MICU1 SLC4A11	1.87e-03	673	145	10	HP_0000539
Disease	lobe size	ADGRG6 MYO3B	2.10e-03	14	145	2	EFO_0007666
Disease	cancer (implicated_via_orthology)	RB1 GDI1 GDI2 PGM3 TOP2A TOP2B	2.16e-03	268	145	6	DOID:162 (implicated_via_orthology)
Disease	Cholestasis	LY96 SORT1 ABCC2 SORL1	2.16e-03	110	145	4	C0008370
Disease	ecosanoids measurement	CYP3A5 ELOVL2 ABCC2	2.53e-03	55	145	3	EFO_0020044
Disease	C-reactive protein measurement	ATXN2L CFAP251 PSD3 NCL ZZEF1 HNRNPC AK7 EIF3CL MICU1 SBK1 SLC6A9 SEC16A EIF3C TOP2B	2.54e-03	1206	145	14	EFO_0004458
Disease	Neuralgia, Supraorbital	CACNA2D1 PRKG1	2.75e-03	16	145	2	C0038870
Disease	Neuralgia	CACNA2D1 PRKG1	2.75e-03	16	145	2	C0027796
Disease	Neuralgia, Atypical	CACNA2D1 PRKG1	2.75e-03	16	145	2	C0234247
Disease	Neuralgia, Stump	CACNA2D1 PRKG1	2.75e-03	16	145	2	C0234249
Disease	Neuralgia, Iliohypogastric Nerve	CACNA2D1 PRKG1	2.75e-03	16	145	2	C0423712
Disease	Neuralgia, Perineal	CACNA2D1 PRKG1	2.75e-03	16	145	2	C0423711
Disease	Paroxysmal Nerve Pain	CACNA2D1 PRKG1	2.75e-03	16	145	2	C0751373
Disease	Nerve Pain	CACNA2D1 PRKG1	2.75e-03	16	145	2	C0751372
Disease	Neuralgia, Ilioinguinal	CACNA2D1 PRKG1	2.75e-03	16	145	2	C0751371
Disease	Neuralgia, Vidian	CACNA2D1 PRKG1	2.75e-03	16	145	2	C0042656
Disease	BMI-adjusted waist circumference, physical activity measurement	FNDC3B ADGRG6 TLE3 PRKG2	3.23e-03	123	145	4	EFO_0007789, EFO_0008002
Disease	Hereditary Diffuse Gastric Cancer	FAT4 ABT1 IDH3B BAP1 EGFR UMPS	3.35e-03	293	145	6	C1708349
Disease	Prostatic Neoplasms	COL5A1 RB1 CYP3A5 CHD3 PRDX2 BAP1 EGFR UMPS TOP2A	3.50e-03	616	145	9	C0033578
Disease	Malignant neoplasm of prostate	COL5A1 RB1 CYP3A5 CHD3 PRDX2 BAP1 EGFR UMPS TOP2A	3.50e-03	616	145	9	C0376358
Disease	Adenocarcinoma of lung (disorder)	NCL BAP1 SGK2 EGFR TOP2A	3.58e-03	206	145	5	C0152013
Disease	Stomach Neoplasms	FAT4 ABT1 IDH3B BAP1 EGFR UMPS	3.58e-03	297	145	6	C0038356
Disease	lobe attachment	FAT4 LIPN ADGRG6 MYO3B LRBA	3.65e-03	207	145	5	EFO_0007667
Disease	Liver carcinoma	GPM6A RB1 PRDX2 CDK14 INPP4B EGFR UMPS TOP2A	3.69e-03	507	145	8	C2239176
Disease	oral squamous cell carcinoma (is_marker_for)	NAIP PRDX2 EGFR	3.72e-03	63	145	3	DOID:0050866 (is_marker_for)
Disease	Malignant neoplasm of stomach	FAT4 ABT1 IDH3B BAP1 EGFR UMPS	3.76e-03	300	145	6	C0024623
Disease	keratoconus	COL5A1 FNDC3B COL6A1	4.24e-03	66	145	3	MONDO_0015486
Disease	corneal hysteresis	FNDC3B COL6A1	4.30e-03	20	145	2	EFO_0010066
Disease	ovarian neoplasm	MECOM BAP1 HOXD1 EGFR	4.39e-03	134	145	4	C0919267
Disease	Mammary Carcinoma, Human	RB1 RPS7 MECOM BAP1 EGFR TLE3 UMPS TOP2A	4.54e-03	525	145	8	C4704874
Disease	Mammary Neoplasms, Human	RB1 RPS7 MECOM BAP1 EGFR TLE3 UMPS TOP2A	4.54e-03	525	145	8	C1257931
Disease	Mammary Neoplasms	RB1 RPS7 MECOM BAP1 EGFR TLE3 UMPS TOP2A	4.65e-03	527	145	8	C1458155
Disease	interleukin-2 receptor subunit alpha measurement	GDI2 SLC6A5	4.74e-03	21	145	2	EFO_0010587
Disease	chronic myeloid leukemia (is_implicated_in)	CYP3A5 ABCC2	4.74e-03	21	145	2	DOID:8552 (is_implicated_in)
Disease	Malignant neoplasm of ovary	MECOM BAP1 HOXD1 EGFR	4.74e-03	137	145	4	C1140680
Disease	urate measurement	NEBL PSD3 MECOM CHD3 GCNT2 BIRC6 INPP4B HOXD1 NRXN1 MYO3B PRRC2B	4.80e-03	895	145	11	EFO_0004531

Protein segments in the cluster

Peptide	Gene	Start	Entry
SVLAKKVSGFKVYSL	VANGL2	296	Q9ULK5
VAALAKAGLFYTGIK	NAIP	296	Q13075
GKATIEGYYQKLSKA	PGM3	176	O95394
FGTEKVGFLYKKSDG	ASAP3	301	Q8TDY4
GYSLASLLAKVAAGK	BIRC6	1256	Q9NR09
KAGKYTVSVFAKSTG	BTK	311	Q06187
KETGAFYGREFKTAK	ADORA3	216	P0DMS8
KLDKLGEGTYATVFK	CDK18	146	Q07002
KGKPVTLKDIFGAYS	CYP3A5	166	P20815
GTFNKKSKGYTDVVR	ADAMTS5	736	Q9UNA0
KKSFKPDFGAESIYG	COPB2	421	P35606
EAFGDGYHLTLTKKK	ABCA12	1566	Q86UK0
GKAKSGYFLSISDSK	ADGRG6	216	Q86SQ4
KLAKTGEGSYGVVFK	CDKL4	6	Q5MAI5
VKIKNGKVYFTSDAG	FAT4	4271	Q6V0I7
LKSKFGSGYSLRAKV	ABCA3	1601	Q99758
KDFTKGFSPESKGYA	BAP1	116	Q92560
YGLSAGVFTKDIDKA	ALDH1A1	426	P00352
LGEGSYATVYKGKSK	CDK14	141	O94921
KSGVDADSSYFKIFK	DHRS7	321	Q9Y394
LLKQGEGFSVYAAKS	DMWD	256	Q09019
DVKVKNGTTYEGIFK	ATXN2L	136	Q8WWM7
SFEVLGYTNSKGKKA	CFAP251	1051	Q8TBY9
YAYGLKTADGKGEKR	C16orf46	251	Q6P387
DIGYIFKEKFAKAVG	RB1	421	P06400
KRTGKTKGYGFVSFK	RBM42	416	Q9BTD8
AYKIVLAGDAAVGKS	RASEF	541	Q8IZ41
EKFYGVTVFKALKLG	P3H1	511	Q32P28
GKGGKYTKSDFKEYE	PPIL4	326	Q8WUA2
KYFGSTGLVGLQDKK	MECOM	671	Q03112
YVTSSFKGAFKDEVK	MORC1	276	Q86VD1
KKYTRFEKIGQGASG	PAK3	281	O75914
SDVEAIFSKYGKIAG	HNRNPCL1	31	O60812
DFKVTEGSFVYKGGK	GDI2	101	P50395
VFGTKGFFLEDKKTK	LIPN	226	Q5VXI9
GFTLKVDALYKVEAG	FRAS1	3801	Q86XX4
SEPEAAYTFKGAKVK	FRAS1	3976	Q86XX4
SDVEAIFSKYGKIVG	HNRNPC	31	P07910
YAKDGKRFASGSADK	IFT122	61	Q9HBG6
YTLQSKKDFSKFGAG	TMBIM4	141	Q9HC24
SDVEAIFSKYGKIAG	HNRNPCL2	31	B2RXH8
KKGKLAEYGAASPSS	HOXD1	216	Q9GZZ0
QIYGVFDEKKKTLFG	MTMR12	116	Q9C0I1
KSYSVGVAYKTLGKF	FSD1L	396	Q9BXM9
GVAYKTLGKFDQLGK	FSD1L	401	Q9BXM9
TTGAIKDLYGDFKIT	GPM6A	106	P51674
FLASKKESVVYGGIS	GCNT2	151	Q8N0V5
SDVEAIFSKYGKIAG	HNRNPCL3	31	B7ZW38
GYAKLVDFGFAKKIG	PRKG1	496	Q13976
GYASFKVGELLKSKE	INPP4B	146	O15327
VKIFKSQGAALDKYA	MDH1	106	P40925
YFFGADLKGKLTIKN	MICU1	281	Q9BPX6
KVFDVTKGSKFYGPA	PGRMC2	126	O15173
AYIRKLTGGADKGKF	NPLOC4	166	Q8TAT6
SLGNKERSKGVFYKA	NRDE2	1101	Q9H7Z3
QLGLGYKGTFKFKAE	LRBA	381	P50851
SDVEAIFSKYGKIAG	HNRNPCL4	31	P0DMR1
EKGSYSALLAKKGEF	ABCC2	841	Q92887
KYKLVRKIGSGSFGD	CSNK1A1L	16	Q8N752
SKGKEEYIATFKGSE	NRXN1	276	Q9ULB1
FEGATVLKALKSGYE	P3H2	506	Q8IVL5
VDGAFKEVKLSDYKG	PRDX2	21	P32119
DLYALSKIVASKGGF	KDM5A	116	P29375
AEGYLKLVDFGFAKK	PRKG2	586	Q13237
SVAAGKAKKQVFYGE	PNPLA7	306	Q6ZV29
GKSKGIAYIEFKTEA	NCL	426	P19338
GYGASKKKKASASSF	INO80C	36	Q6PI98
YKIFVSGKSGVGKTA	CPLANE2	56	Q9BU20
EEFELLGKAYGKAKS	EIF3C	81	Q99613
VCKLKFEGKTFYVIG	FRMD3	261	A2A2Y4
FEGKTFYVIGTQKEK	FRMD3	266	A2A2Y4
EFKKIKVLGSGAFGT	EGFR	711	P00533
EEFELLGKAYGKAKS	EIF3CL	81	B5ME19
AAAAGGKKRSYTKDY	ABT1	91	Q9ULW3
KFSGVEKIKTIGSTY	ADCY2	931	Q08462
TVVYFGKEGLSKVKS	CSGALNACT2	306	Q8N6G5
AFDYATKKGRGKVTA	IDH3B	201	O43837
DALKSSVDAVKYFGK	COL6A1	111	P12109
AGKEVKNGFSKAYFT	ELOVL2	271	Q9NXB9
ASAFGGEIKSIAAKY	CACNA2D3	46	Q8IZS8
TAKGITDYKKGFSFA	CACNA2D1	326	P54289
LGEGTYATVYKGKSK	CDK16	171	Q00536
GKRKKGGSYVFQSDE	CHD3	301	Q12873
LISSTGKDGKYKSVY	FNDC3A	311	Q9Y2H6
GKDGKYKSVYVGEET	FNDC3A	316	Q9Y2H6
SDKGRDGKYKIIYSG	FNDC3B	321	Q53EP0
FKLVGKETFYVGAAK	FAIM	46	Q9NVQ4
KVCKASSVIFGLKGY	ILKAP	96	Q9H0C8
KKGGIFSAEFLKVFI	BNIP3L	176	O60238
IKIGNDYSFTSKKDG	AKNAD1	26	Q5T1N1
VKAKKGSQAFLVSIY	COL5A1	106	P20908
KGTCASVKVYKLGIF	DTHD1	281	Q6ZMT9
KGKSDIKYYAKTGDT	CFHR4	531	Q92496
FSKGKYKCVVEAISG	LY96	126	Q9Y6Y9
KTTEKGFGLVAYAAD	KHDC4	556	Q7Z7F0
DFKVVEGSFVYKGGK	GDI1	101	P31150
LKGGKAYSKLGFADL	FAM102A	91	Q5T9C2
AYKEFKGFGTEVTEK	ETNK1	376	Q9HBU6
VSKYEKLAKIGQGTF	CDK9	16	P50750
KGTYGKVDLVVYKGT	SBK1	61	Q52WX2
KVIGKGSFGQVVKAY	DYRK2	226	Q92630
IAAYAFTSFGKKLTK	CROT	396	Q9UKG9
TGKKKLQYLSFGDFA	FIBP	186	O43427
TVSYFLKAAAGIEKG	MRPL11	86	Q9Y3B7
DKFGKVKFAVLQTYG	HPD	126	P32754
AKYSGVLSSIGKIFK	MTCH1	231	Q9NZJ7
KGIKKGGVTENTSYY	GTF2F1	111	P35269
GKNKAVGKYITTTLF	SLC4A11	351	Q8NBS3
DLGKSFKTIGVKIYS	SORT1	291	Q99523
TSLGAIFGVKKYADA	SQOR	231	Q9Y6N5
YGKSFKKISDKLNFG	SORL1	141	Q92673
ETFSGVYKKLTGKDV	RPS7	171	P62081
YGKVLLAKRKSDGAF	SGK2	46	Q9HBY8
SDGAFYAVKVLQKKS	SGK2	56	Q9HBY8
IKYYKGLGTSTAKEA	TOP2B	631	Q02880
KKGDGYVDTESKFLK	SELENOW	61	P63302
LAKGIKTSGKVVYFT	SLC6A5	411	Q9Y345
GSKAEFIVGGKYKLV	CSNK1A1	6	P48729
KYKLVRKIGSGSFGD	CSNK1A1	16	P48729
IVAGKYSKEFFTKKG	SRPK1	581	Q96SB4
FYIKGEKKSTCEATG	SVEP1	2176	Q4LDE5
DLKNLFSKYGKVVGA	SAFB	421	Q15424
FSKYGKVVGAKVVTN	SAFB	426	Q15424
SKVVLGDSKEGAFAY	SMCR8	121	Q8TEV9
LSVNYGKKSKLGFSI	TUBA4B	96	Q9H853
IAKYSDGASKAAGVF	CMTM3	121	Q96MX0
IKKTKICSEFIYGGS	WFDC6	96	Q9BQY6
ANFTGGKIAKDVKYP	USP42	321	Q9H9J4
AISESLIGTEGKKFY	ZNF197	356	O14709
AQAGFGVYTKKTTKL	SEC16A	1746	O15027
GHILYSKEDATKGKF	TMED10	81	P49755
VEAYGKKFEVKTVSG	SGCD	131	Q92629
IGEGTYSKVKEAFSK	TSSK3	16	Q96PN8
KTRYKLKVEGYSGTA	TNC	2096	P24821
IVKSYEEAGFKSQKG	TIGD4	371	Q8IY51
KECGKAFIYGSSLVK	ZNF331	386	Q9NQX6
QTLYKKFVKSTGFLG	TMEM116	111	Q8NCL8
TVKKQYEGGIFKIAS	UMPS	321	P11172
GKDGKSKYSTLSLFD	PRRC2B	11	Q5JSZ5
KKTYVTLGVAVAGFL	SLC6A9	496	P48067
KLFSGDDKGKIVYSS	TECPR2	141	O15040
TDLKNLFSKYGKVVG	SAFB2	421	Q14151
LFSKYGKVVGAKVVT	SAFB2	426	Q14151
AITAATLKFTEGKGY	SPTB	586	P11277
ADDKYIVTGSGDKKA	TLE3	751	Q04726
KYYKGLGTSTSKEAK	TOP2A	611	P11388
VGEKTSEFKAKGYLA	TTC7B	461	Q86TV6
KESGLKYKSFLDFAG	ZZEF1	751	O43149
SKLIKGSSYGKVFVI	SLC46A2	396	Q9BY10
YTGVSGTIFKETKKE	TGM1	621	P22735
GDSYFTGKKTIETVK	WDR3	741	Q9UNX4
KGIKSSGKVVYFTAL	SLC6A14	256	Q9UN76
INLGKGSYAKVKSAY	TSSK2	16	Q96PF2
KAKYEFLFGRSEGKA	PSD3	26	Q9NYI0
DLTFGYKLQGKEAVK	WDR81	546	Q562E7
GKKARKFAAYVVAAG	AK7	201	Q96M32
TIGKGTYGKVFKVLN	MYO3A	26	Q8NEV4
ETIGKGTYGKVYKVT	MYO3B	31	Q8WXR4
SGKYGLVVKNKYGSE	MYOM1	1641	P52179
GAFISEAKYKGTIKA	NEBL	81	O76041
SAVFYKKEVGAGTAV	NEBL	591	O76041